Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1050.Time spend outdoors in summer,48398,0.0244963700370126,0.032235866410567,-0.0386859281276987,0.0876786682017238,0.44731562801405
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1060.Time spent outdoors in winter,44800,-0.0383875285182802,0.0365184554829456,-0.109963701264854,0.0331886442282932,0.293187675666159
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1070.Time spent watching television (TV),49925,0.114986045287517,0.0327768535317838,0.0507434123652206,0.179228678209813,0.000452015962763008
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1080.Time spent using computer,44728,-0.11811609783947,0.0344497013327147,-0.185637512451591,-0.0505946832273492,0.000607788720851183
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1090.Time spent driving,42215,-0.00488674484094744,0.037760593290224,-0.0788975076897866,0.0691240180078917,0.897031631741554
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1160.Sleep duration,51427,-0.00346241269031474,0.0295382782095302,-0.061357437980994,0.0544326126003645,0.906688315650422
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,33900,0.00103073022748362,0.0130079390484102,-0.0244648303074003,0.0265262907623676,0.936844560712485
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,33900,0.00919017587957304,0.0116872545306698,-0.0137168430005398,0.0320971947596859,0.431687035964518
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,33900,0.0132235917414897,0.0139793881701906,-0.014176009072084,0.0406231925550633,0.344205960664867
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,33900,0.0129694746694386,0.0143007888314774,-0.0150600714402571,0.0409990207791342,0.364479508465923
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,33900,0.0287030138104871,0.0145145058822371,0.000254582281302394,0.0571514453396719,0.0480096563346747
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,33900,0.00821791743122594,0.0277495817754861,-0.0461712628487269,0.0626070977111788,0.767125375662539
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,33900,-0.0382861051715292,0.0278157739932568,-0.0928050221983125,0.0162328118552541,0.16872517548809
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,33900,0.0224275326542254,0.0212841520475538,-0.01928940535898,0.0641444706674308,0.292038162709636
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,33900,0.0019744340905677,0.0152763893709458,-0.0279672890764861,0.0319161572576215,0.897164617132983
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,33900,-0.00864678961848886,0.010500343935201,-0.0292274637314827,0.011933884494505,0.410257690354582
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,33900,0.0126308805581293,0.0146130911167667,-0.0160107780307334,0.041272539146992,0.387415518189753
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,33900,-0.00209855631592183,0.00894758136697292,-0.0196358157951887,0.0154387031633451,0.814571682852989
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,33900,-0.00316581755117238,0.0111821724607218,-0.0250828755741871,0.0187512404718424,0.777096476783102
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,33900,0.0117218532900927,0.0160140999341681,-0.0196657825808768,0.0431094891610621,0.464204555668537
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,33900,0.0122708845448544,0.0152951126559143,-0.0177075362607376,0.0422493053504463,0.42241415346141
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,33900,0.00481023462312929,0.021419667671627,-0.0371723140132597,0.0467927832595183,0.822317940450159
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,33900,-0.0150745816768914,0.0197483426868773,-0.0537813333431708,0.0236321699893881,0.445283281673866
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,33900,-0.0151411408535301,0.0119350989185205,-0.0385339347338302,0.00825165302677005,0.204606816682921
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,33900,-0.00642671269129613,0.0112038980959956,-0.0283863529594475,0.0155329275768552,0.566242695924577
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,33900,0.0117925706653491,0.0148675270807226,-0.0173477824128672,0.0409329237435655,0.427695010088667
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120040.Fatigue severity over the past week,33906,0.110391979041843,0.0510138891224202,0.0104047563618997,0.210379201721787,0.0304924412140795
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,33903,0.0821638674266328,0.0509428617308525,-0.0176841415658382,0.182011876419104,0.10680762461726
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,33903,0.109364317098191,0.0545644177217804,0.00241805836350177,0.216310575832881,0.0450647416150569
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120098.Mobility problems today,33910,0.120054939515159,0.0602391389868794,0.00198622710087527,0.238123651929443,0.0462931655155994
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120099.Self-care problems today,33910,0.110497524777786,0.0949918020876946,-0.0756864073140953,0.296681456869668,0.244764653110894
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120100.Problems doing usual activities,33910,0.100789501481276,0.0571033996685179,-0.0111331618690191,0.212712164831571,0.0775901532588801
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120101.Pain or discomfort today,33910,0.0532712057702409,0.0513659346786843,-0.0474060261999804,0.153948437740462,0.299719452071595
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120102.Anxiety or depression today,33910,0.16973467116722,0.0599049794218018,0.0523209115004887,0.287148430833952,0.0046153462238209
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120103.Scale to indicate how health is today,33874,-0.0060535158218225,0.00385678568755958,-0.0136128157694393,0.00150578412579427,0.116547512178996
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,33886,0.0812868112122693,0.0619715060463462,-0.0401773406385693,0.202750963063108,0.18965991076491
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",33862,0.0839436851143762,0.0621517521400853,-0.0378737490801909,0.205761119308943,0.176848202750576
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",33892,0.0710801648071334,0.050299244879513,-0.027506355156712,0.169666684770979,0.157645847551233
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,33886,0.117621411487184,0.0516793822645471,0.0163298222486717,0.218913000725696,0.0228693267548271
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,33896,0.0814084348883746,0.0626994652914572,-0.0414825170828815,0.204299386859631,0.194184647933476
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,33867,0.0908313400165315,0.0649096525216689,-0.0363915789259395,0.218054258959002,0.161740922487689
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,33891,0.0589724306663665,0.0674121690009847,-0.0731554205755635,0.191100281908296,0.381702859021669
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,33883,0.139440984216427,0.0981164021634064,-0.0528671640238501,0.331749132456703,0.155297757350872
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,33844,-0.0121770102760044,0.13286275446057,-0.272588009018721,0.248233988466712,0.926977249143939
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31569,0.109966356735564,0.0673498101892298,-0.0220392712353268,0.241971984706454,0.102562855546663
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49116,0.0728883681082763,0.0706504063373724,-0.0655864283129735,0.211363164529526,0.302233778733765
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47301,0.0465970438116605,0.0462489422874196,-0.0440508830716819,0.137244970695003,0.313692407357182
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1289.Cooked vegetable intake,50904,-0.121178841414011,0.0308901407401573,-0.18172351726472,-0.0606341655633031,8.77114920180117e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50419,-0.173988621138344,0.0334655770612794,-0.239581152178452,-0.108396090098237,2.01845203762985e-07
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1309.Fresh fruit intake,50952,-0.215846402048186,0.0320427844636895,-0.278650259597017,-0.153042544499354,1.65915643208305e-11
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1319.Dried fruit intake,49224,-0.187437968798579,0.0324226726678194,-0.250986407227505,-0.123889530369653,7.51145794713783e-09
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X134.Number of self-reported cancers,51711,0.0908646977835095,0.0530558482021174,-0.0131247646926406,0.194854160259659,0.0867931822824385
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51711,0.117666026063523,0.0308159797793817,0.0572667056959346,0.178065346431111,0.000134647543710553
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X136.Number of operations, self-reported",51711,0.00627228394717868,0.0311607739764315,-0.0548028330466271,0.0673474009409844,0.840475035761986
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X137.Number of treatments or medications taken,51711,0.0592509955893773,0.0300576074076045,0.00033808507047247,0.118163906108282,0.0487056259966846
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1438.Bread intake,50776,0.011938570530953,0.00254609688813166,0.00694822063021492,0.016928920431691,2.75960415401389e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1458.Cereal intake,50335,-0.0436315005532746,0.0306236430472003,-0.103653840925787,0.016390839819238,0.15423714582544
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1488.Tea intake,50806,-0.00219866792191658,0.0023673668431846,-0.00683870693455839,0.00244137109072523,0.353032430623842
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1498.Coffee intake,49548,-0.0601816438234373,0.030957975243401,-0.120859275300503,0.000495987653628668,0.0519091836983797
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1528.Water intake,50015,-0.107673496038891,0.0315734492056256,-0.169557456481918,-0.0457895355958653,0.000650025922050025
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1568.Average weekly red wine intake,41109,-0.10811762824925,0.0382209552212286,-0.183030700482859,-0.0332045560156422,0.00467856199200321
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41109,0.00383242263817339,0.0381873778736719,-0.0710148379942236,0.0786796832705704,0.920061034143896
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,41131,0.0727219631036593,0.0483342805656337,-0.0220132268049827,0.167457153012301,0.132455438740289
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1598.Average weekly spirits intake,41060,0.0988390846771499,0.0427524554936813,0.0150442719095346,0.182633897444765,0.0207957766873481
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1608.Average weekly fortified wine intake,41136,0.0429435115063771,0.0651405864487108,-0.0847320379330961,0.17061906094585,0.509748484138168
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1737.Childhood sunburn occasions,45218,-0.0458908885310193,0.0373102423787448,-0.119018963593359,0.0272371865313205,0.218718161560744
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1807.Father's age at death,44314,-0.00206265572004652,0.00273843530371559,-0.00742998891532906,0.00330467747523603,0.45132413182108
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1845.Mother's age,35084,0.00374284918401812,0.00620276833014539,-0.00841457674306684,0.0159002751111031,0.546244903739579
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1873.Number of full brothers,51206,0.053723353567022,0.0298370992675506,-0.00475736099737713,0.112204068131421,0.071784225322583
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1883.Number of full sisters,51211,0.0711739406864039,0.0297645506458957,0.0128354214204484,0.129512459952359,0.0167988119162308
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20015.Sitting height,51522,-0.0182216081249619,0.00313743584357898,-0.0243709823783767,-0.0120722338715471,6.40054891398402e-09
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20016.Fluid intelligence score,33197,-0.0674685727971776,0.0494606673012675,-0.164411480707662,0.0294743351133067,0.172575851450634
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20018.Prospective memory result,33535,0.068560994064756,0.0642665379560417,-0.0574014203290857,0.194523408458598,0.286080316240353
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33070,0.00146019560835691,0.00437045381708834,-0.00710589387313624,0.0100262850898501,0.738307570125932
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33044,-0.00398285616166146,0.00435492249941834,-0.0125185042605214,0.0045527919371985,0.360446130635984
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20023.Mean time to correctly identify matches,51404,0.00551656990062423,0.00256207390043755,0.000494905055766635,0.0105382347454818,0.0313144942388488
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48516,0.00556407993432481,0.00525768912784476,-0.00474099075625092,0.0158691506249005,0.289940798916536
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48092,0.0128699313441424,0.0114171551185619,-0.00950769268823896,0.0352475553765237,0.259650338677532
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48063,0.0284216092917933,0.0154866381964998,-0.00193220157334629,0.0587754201569329,0.0664835553497561
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48076,0.0147409057461043,0.012555047353696,-0.00986698706713993,0.0393487985593485,0.240366022891342
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48082,0.00167836411418068,0.00938357732418685,-0.0167134474412255,0.0200701756695869,0.85804770280288
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48239,-0.00296942006554876,0.00682221512833731,-0.0163409617170899,0.0104021215859924,0.6633795041404
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48179,0.00274990420567142,0.0085759670178114,-0.0140589911492389,0.0195587995605818,0.748476664815042
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48088,-0.00117936660709266,0.0110104603130628,-0.0227598688206957,0.0204011356065104,0.914700014574097
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48236,0.000117021681186197,0.00771362709865471,-0.015001687432177,0.0152357307945494,0.987896066462828
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48290,0.0035628023079909,0.00584642576157562,-0.00789619218469732,0.0150217968006791,0.542266228408732
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48168,0.038166439297163,0.00816409749236818,0.0221648082121214,0.0541680703822047,2.95696717870311e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49886,-0.00630370459512857,0.0058357095385381,-0.0177416952906632,0.0051342861004061,0.280065571963171
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49761,0.0079727289031101,0.00849975177850541,-0.0086867845827605,0.0246322423889807,0.348255674595663
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49693,-0.0441725385346969,0.018211515444299,-0.079867108805523,-0.00847796826387085,0.0152931058271782
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49730,0.00360937819466365,0.00914995822892176,-0.014324539934023,0.0215432963233503,0.693237869918132
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49823,0.00574270821478849,0.00672759006038804,-0.00744336830357206,0.018928784733149,0.393331641218289
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49714,0.00445104832943891,0.0124480166579216,-0.0199470643200875,0.0288491609789653,0.720667457387863
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49711,0.0147342725391282,0.0109986731783393,-0.00682312689041675,0.0362916719686732,0.180374169373576
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49742,-0.000382959968354106,0.00874017204197023,-0.0175136971706158,0.0167477772339076,0.965051365275324
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49757,0.00463208542964127,0.00977198578440172,-0.0145210067077861,0.0237851775670686,0.635492017038291
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49913,0.00278579072551334,0.00507315718330848,-0.00715759735377129,0.012729178804798,0.582925393282397
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49770,0.0293075166744907,0.00798148380302171,0.0136638084205681,0.0449512249284133,0.000241212819810085
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46322,-0.00117253961268687,0.00825681056518129,-0.0173558883204422,0.0150108090950685,0.887074376936087
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46180,0.0601552904020674,0.0323246503015591,-0.00320102418898845,0.123511604993123,0.0627615345019673
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46177,0.00322246384975534,0.0333996225786944,-0.0622407964044857,0.0686857241039964,0.923138624285135
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46241,-2.32924866346214e-05,0.00912957855468923,-0.0179172664538255,0.0178706814805563,0.997964365829094
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46192,0.0430621510916077,0.0191742389103379,0.00548064282734543,0.0806436593558699,0.0247246666885076
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46205,0.0117790256369972,0.014119980174677,-0.0158961355053698,0.0394541867793641,0.404171938201399
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46186,0.0193749010786561,0.017077182351068,-0.0140963763294372,0.0528461784867495,0.256576822175311
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46183,0.0378292447352039,0.0166633673831201,0.00516904466428855,0.0704894448061193,0.0232049507602693
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46204,0.0234402045560157,0.0121057428128241,-0.000287051357119549,0.0471674604691509,0.0528453749485389
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46206,0.0266563098853484,0.0146254757844864,-0.00200962265224487,0.0553222424229417,0.0683785689119602
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46394,0.00522415026144839,0.00608524178803422,-0.00670292364309868,0.0171512241659955,0.390628512440837
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46280,0.0192915111237578,0.00875349563025794,0.00213465968845219,0.0364483625590633,0.0275443329211081
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20127.Neuroticism score,45869,0.0533359099115435,0.0313490300603765,-0.00810818900679438,0.114780008829881,0.088890384443448
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33197,0.0507243415723763,0.0498300549892344,-0.0469425662065231,0.148391249351276,0.30873146823352
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20161.Pack years of smoking,31700,0.0182014522734941,0.00513192046550048,0.00814288816111319,0.0282600163858751,0.000392532391160239
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31700,0.0185478015511513,0.00506211816934117,0.00862604993924259,0.02846955316306,0.000250040364535023
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20191.Fluid intelligence score,31364,-0.017584500837389,0.0561869409019074,-0.127710905005128,0.0925419033303495,0.754317322069694
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31364,0.0069912866204973,0.0576431412908747,-0.105989270309617,0.119971843550612,0.903468306963023
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20240.Maximum digits remembered correctly,30627,-0.0849460259250619,0.0598394030333348,-0.202231255870398,0.0323392040202744,0.155784399741664
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20255.Spirometry QC measure,45422,0.0490715558361188,0.0413399490284114,-0.0319547442595676,0.130097855931805,0.235231177707414
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20261.avMSE,30394,-0.00680220062937829,0.00498407185075927,-0.0165709814568665,0.00296658019810988,0.172371419994722
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20262.Myopia diagnosis,30394,0.0544673531921073,0.0741411050206991,-0.090849212648463,0.199783919032678,0.4625850393072
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20280.Glucose-lactate,39997,0.0192522263211547,0.00325999371611629,0.0128626386375668,0.0256418140047426,3.58688132732644e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40035,0.0179924775164238,0.00312143134755695,0.0118744720752122,0.0241104829576354,8.36101596780064e-09
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32988,-0.0128715595323007,0.0149741026967329,-0.0422208008178972,0.0164776817532958,0.3900403116964
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32985,0.0208318088404013,0.0278010098226779,-0.0336581704120474,0.0753217880928499,0.453685962344517
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32983,0.02437021703336,0.0351487645026389,-0.0445213613918123,0.0932617954585323,0.488112000171619
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32983,-0.0068673458518004,0.0140235125526675,-0.0343534304550287,0.0206187387514279,0.624357191007971
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32983,0.0122844142591037,0.0279203570484944,-0.0424394855559453,0.0670083140741527,0.65996233510896
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32991,-0.0388037486445884,0.0345583673449619,-0.106538148640714,0.0289306513515369,0.261534177870166
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32991,-0.0370437284791495,0.0226397057026629,-0.0814175516563687,0.00733009469806973,0.101828657040465
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32991,-0.00447303544584396,0.0248748859133602,-0.05322781183603,0.0442817409443421,0.857297092592509
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32991,-0.00791861758389694,0.0406824397474799,-0.0876561994889576,0.0718189643211637,0.845675808396537
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32991,-0.0599855352407285,0.0490706382872337,-0.156163986283707,0.0361929158022497,0.221577915549159
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32991,0.00154111460604063,0.0256819485476822,-0.0487955045474165,0.0518777337594978,0.952150908101018
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32991,-0.0317760729038982,0.0503340100454152,-0.130430732592912,0.0668785867851157,0.527858526850309
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32991,-0.033142199613525,0.0345426672206275,-0.100845827365955,0.0345614281389049,0.337355799324275
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32989,0.0268144752295359,0.0409070684042587,-0.0533633788428111,0.106992329301883,0.512165250669244
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32989,-0.011207674984042,0.0189979369046887,-0.0484436313172318,0.0260282813491478,0.555245356983427
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32989,-0.00313302188056665,0.0306392883801506,-0.0631860271056618,0.0569199833445285,0.91855663691492
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32991,-0.00126459452951058,0.0449597279673109,-0.0893856613454398,0.0868564722864187,0.977561299501537
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20600.Liking for adding salt to foods,34842,0.0466088790072525,0.0457182642815071,-0.0429989189845015,0.136216676999006,0.30799866326127
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20601.Liking for aniseed,34842,0.00230540573339871,0.0456645764946397,-0.0871971641960951,0.0918079756628926,0.95973635738974
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20602.Liking for apple juice,34842,0.0976919160585894,0.045741991697797,0.00803761233090738,0.187346219786272,0.0327258776738843
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20603.Liking for apples,34842,-0.0218742999557309,0.04689504691129,-0.113788591901859,0.0700399919903975,0.640901609793656
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20604.Liking for asparagus,34842,-0.144834903362822,0.0469218427206928,-0.23680171509538,-0.0528680916302645,0.00202906728698917
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20605.Liking for aubergine,34842,-0.209424977504418,0.0458873879410536,-0.299364257868883,-0.119485697139953,5.07911605344803e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20606.Liking for avocados,34842,-0.0912190789654364,0.0468719733094898,-0.183088146652036,0.000649988721163605,0.0516657504585407
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20607.Liking for bacon,34842,0.0859096457055104,0.0456745328077443,-0.00361243859766837,0.175431730008689,0.060012247694204
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20608.Liking for baked or steamed fish,34842,-0.193608699551674,0.0469086288310884,-0.285549612060607,-0.10166778704274,3.69822781339005e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20609.Liking for bananas,34842,-0.066363327668217,0.0476745194150019,-0.159805385721621,0.0270787303851868,0.163949699066345
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,34842,-0.0244090785209037,0.0455515028552887,-0.11369002411727,0.0648718670754622,0.592069064495201
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20611.Liking for beef steak,34842,0.0865290448957676,0.0454959084122398,-0.00264293559222238,0.175701025383758,0.0572107999799409
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20612.Liking for beetroot,34842,-0.0725620005346107,0.0471083770249133,-0.164894419503441,0.0197704184342194,0.123512719949302
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20613.Liking for bell pepper,34842,-0.133801252524958,0.0459844680432031,-0.223930809889636,-0.0436716951602802,0.00362537813480196
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20614.Liking for bicycling,34842,-0.0998453967560101,0.0458064789426539,-0.189626095483612,-0.0100646980284085,0.0293004577648539
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20615.Liking for biscuits,34842,0.0884585535306017,0.0459262403242787,-0.00155687750498455,0.178473984566188,0.0541191030852407
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20616.Liking for bitter foods,34842,-0.105361077041087,0.0455812493124777,-0.194700325693543,-0.0160218283886306,0.0208247134656732
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20617.Liking for bitter or ale,34842,0.0016887986607228,0.0476232765577773,-0.0916528233925207,0.0950304207139663,0.971712329651616
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20618.Liking for black olives,34842,-0.198189237635216,0.0461413099630455,-0.288626205162785,-0.107752270107647,1.76071106004876e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20619.Liking for black pepper,34842,0.0239937902460214,0.0463292887611638,-0.0668116157258596,0.114799196217902,0.604541313492468
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20620.Liking for blue cheese,34842,-0.0760590778535236,0.0460326778401011,-0.166283126420122,0.0141649707130746,0.0985068197274238
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20621.Liking for bolognese sauce,34842,0.0209982946231218,0.0461155936347958,-0.0693882689010779,0.111384858147321,0.648873861174367
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20622.Liking for broad beans,34842,-0.070425467657757,0.0457064874415837,-0.160010183043261,0.0191592477277471,0.123391092582953
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20623.Liking for broccoli,34842,-0.112391752044108,0.0479678705309557,-0.206408778284781,-0.0183747258034344,0.0191449193643303
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20624.Liking for brown rice,34842,-0.128603249246448,0.0460603323536779,-0.218881500659656,-0.0383249978332388,0.00524692804234816
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20625.Liking for brussel sprouts,34842,-0.0202122869104456,0.0464186313631516,-0.111192804382223,0.0707682305613315,0.663255916736587
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20626.Liking for burgers (meat),34842,0.0420566456689869,0.0454500253293788,-0.0470254039765956,0.131138695314569,0.354811512075246
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20627.Liking for burn of spicy foods,34842,-0.00659697732276305,0.0462289008626778,-0.0972056230136115,0.0840116683680854,0.886527952752693
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20628.Liking for butter on bread,34842,0.142760332051193,0.0466746302335377,0.0512780567934594,0.234242607308927,0.00222919511715534
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20629.Liking for butternut squash,34842,-0.153563910951668,0.0461167668410012,-0.24395277396003,-0.0631750479433051,0.000871820579655503
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20630.Liking for cabbage,34842,-0.0547039381286525,0.0465947202498817,-0.146029589818421,0.0366217135611156,0.240407030726467
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20631.Liking for cake,34842,0.0626216083935504,0.0460211808634017,-0.027579906098717,0.152823122885818,0.173634018719944
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20632.Liking for cake icing,34842,0.0163960647776456,0.045580225327234,-0.0729411768637331,0.105733306419024,0.719064735319254
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20633.Liking for capers,34842,-0.118297691245021,0.0454821654040128,-0.207442735436886,-0.0291526470531555,0.00930927569228804
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20634.Liking for cauliflower,34842,0.0222212393823516,0.0468958397326498,-0.069694606493642,0.114137085258345,0.635622229112658
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20635.Liking for cereal or granola bar,34842,-0.048246250506354,0.0459190436544414,-0.138247576069059,0.0417550750563512,0.293429745061227
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20636.Liking for cheesecake,34842,0.00145526919072193,0.0458741680473341,-0.0884581001820528,0.0913686385634967,0.974693511208403
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20637.Liking for cherries,34842,-0.193635139715093,0.0499595360402884,-0.291555830354058,-0.0957144490761274,0.000106911832148559
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20638.Liking for chicken,34842,-0.0566632606564609,0.0483737074854269,-0.151475727327898,0.0381492060149757,0.241479039177867
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20639.Liking for chilli pepper,34842,-0.0723009034551965,0.0458024984508129,-0.16207380041879,0.0174719935083968,0.114472939193395
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20640.Liking for chips or french fries,34842,0.118111331732298,0.0463555646413447,0.0272544250352624,0.208968238429334,0.0108503036491815
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20641.Liking for cigarette smoking,34842,0.0397627457240531,0.0762443316309041,-0.109676144272519,0.189201635720625,0.60201751200792
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20642.Liking for cod,34842,-0.122340762587055,0.0475319402034541,-0.215503365385825,-0.0291781597882852,0.0100707129077243
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20643.Liking for coffee with sugar,34842,0.0753288480371981,0.0523484847937245,-0.0272741821585019,0.177931878232898,0.150184036489589
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20644.Liking for coffee without sugar,34842,-0.107098735496515,0.0472918008232464,-0.199790665110078,-0.0144068058829517,0.0235555291589351
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20645.Liking for coriander,34842,-0.139934167036715,0.0459268844512385,-0.229950860561142,-0.0499174735122872,0.00231803094009683
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20646.Liking for corn flakes,34842,0.143841840065687,0.0460062611425241,0.0536695682263395,0.234014111905034,0.00177346211504517
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20647.Liking for cream,34842,0.167812990573653,0.0455968811292022,0.0784431035604168,0.257182877586889,0.000234083361132987
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20648.Liking for croissant,34842,0.0502334187678643,0.0457934088480518,-0.0395216625743172,0.139988500110046,0.272685459066519
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20649.Liking for cucumber,34842,0.0467313879199273,0.0463902627948142,-0.0441935271579086,0.137656302997763,0.313788466548979
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20650.Liking for curry,34842,-0.0816872938189576,0.0463010846810539,-0.172437419793823,0.00906283215590807,0.0777171038534313
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20651.Liking for dairy products,34842,0.0619554607538108,0.0466130681398442,-0.0294061528002837,0.153317074307905,0.183829811534561
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20652.Liking for dark chocolate,34842,-0.187942606719631,0.046215348860692,-0.278524690486587,-0.0973605229526749,4.80418104138477e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,34842,0.0293051840584753,0.0480044019257718,-0.0647834437160375,0.123393811832988,0.541564746150858
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20654.Liking for dried fruit,34842,-0.153984165340421,0.0460294382128115,-0.244201864237532,-0.0637664664433105,0.000824728383589392
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20655.Liking for eggs,34842,-0.0658544757539671,0.0476942362078979,-0.159335178721447,0.0276262272135127,0.167381316806749
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20656.Liking for exercising alone,34842,-0.0366070730668552,0.0459265156592557,-0.126623043758996,0.053408897625286,0.425423231036664
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20657.Liking for exercising with others,34842,-0.15127447053402,0.0458904606964876,-0.241219773499136,-0.0613291675689041,0.000982524109658
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,34842,-0.0923450398731092,0.0464582890802657,-0.18340328647043,-0.00128679327578847,0.0468713480828
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20659.Liking for fatty foods,34842,0.113068458997999,0.0457210718718434,0.0234551581291859,0.202681759866812,0.0134141021670445
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20660.Liking for fresh tomatoes,34842,-0.0516706539639607,0.0508648360463846,-0.151365732614874,0.0480244246869531,0.309728145831246
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20661.Liking for fried chicken,34842,0.0878813414129359,0.0455747204440391,-0.00144511065738082,0.177207793483253,0.0538461302283789
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20662.Liking for fried or battered fish,34842,0.0196410982936988,0.0459394883030567,-0.0704002987802923,0.10968249536769,0.668992873009387
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20663.Liking for fruit,34842,-0.104592184489056,0.0533454612120188,-0.209149288464613,-3.50805134995413e-05,0.0499456780217036
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20664.Liking for garlic,34842,-0.0522591355870155,0.0463793873006554,-0.1431627346963,0.0386444635222691,0.259863654810947
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20665.Liking for gherkins,34842,-0.0286171451873225,0.0458659956048679,-0.118514496572864,0.0612802061982186,0.532687631453374
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20666.Liking for globe artichoke,34842,-0.101402637088337,0.0459729263623521,-0.191509572758547,-0.0112957014181269,0.0274266085271201
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20667.Liking for goat's cheese,34842,-0.188334207650349,0.0455633049137269,-0.277638285281253,-0.099030130019444,3.60147122887145e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20668.Liking for going to a cafe,34842,-0.0340814057786647,0.0464854129984863,-0.125192815255698,0.0570300036983685,0.463475299823242
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20669.Liking for going to the gym,34842,-0.099136430302792,0.0457561022049779,-0.188818390624549,-0.00945446998103529,0.0302859425179461
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20670.Liking for going to the pub,34842,-0.109233961730844,0.0457086377147984,-0.198822891651849,-0.0196450318098394,0.0168758234646688
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20671.Liking for grapefruit,34842,-0.0783510829493791,0.045705952583209,-0.167934750012469,0.0112325841137106,0.0865140622822771
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20672.Liking for green olives,34842,-0.15007486868464,0.0462579824608434,-0.240740514307893,-0.0594092230613872,0.00118111408912364
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20673.Liking for haddock,34842,-0.146458051834141,0.0470606249958799,-0.238696876826065,-0.0542192268422162,0.00186256753961895
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20674.Liking for ham,34842,0.100601222917181,0.0456185944129034,0.01118877786789,0.190013667966471,0.0274571393123489
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20675.Liking for hard cheese,34842,-0.0198797682165398,0.0472708760864558,-0.112530685345993,0.0727711489129134,0.674092396512724
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20676.Liking for herring,34842,-0.159526338542086,0.0456758187032498,-0.249050943200455,-0.0700017338837161,0.000480373759091872
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20677.Liking for honey,34842,-0.0136042198193654,0.0456360494810452,-0.103050876802214,0.0758424371634832,0.765630909864114
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,34842,-0.102770268820151,0.04592812772702,-0.19278939916511,-0.0127511384751915,0.0252661629504251
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20679.Liking for ice cream,34842,0.117265105542972,0.0462444649771269,0.0266259541878032,0.207904256898141,0.0112347336143401
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20680.Liking for jam,34842,0.0230019603910965,0.045862479994847,-0.0668885003988037,0.112892421180997,0.616000355667845
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20681.Liking for kiwi fruit,34842,-0.0778977065059744,0.0459120339184037,-0.167885292986046,0.0120898799740968,0.0897884868127091
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20682.Liking for lager,34842,-0.02124376820644,0.046257916164077,-0.111909283888031,0.0694217474751508,0.646067055510813
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20683.Liking for lamb,34842,0.0343501456904883,0.0458445087424039,-0.0555050914446234,0.1242053828256,0.453708432126724
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20684.Liking for lemons,34842,-0.083116082175953,0.0458518416584694,-0.172985691826553,0.00675352747464698,0.0699054668803528
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20685.Liking for lentils or beans,34842,-0.108082394085252,0.0461588478767387,-0.19855373592366,-0.0176110522468442,0.0192236182950256
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20686.Liking for liver,34842,-0.0771031271586445,0.0456939003750038,-0.166663171893652,0.0124569175763628,0.0915597033221275
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20687.Liking for mackerel,34842,-0.140542156651118,0.0457574039789547,-0.230226668449869,-0.0508576448523663,0.00213563881699717
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20688.Liking for marzipan,34842,-0.0919765276495041,0.0452577704270878,-0.180681757686596,-0.00327129761241204,0.0421505758632044
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20689.Liking for mayonnaise,34842,0.074982597191405,0.0461298074758969,-0.015431825461353,0.165397019844163,0.104092903351941
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20690.Liking for melon,34842,-0.0712880866283379,0.0482713446183772,-0.165899922080357,0.0233237488236814,0.139754230590004
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20691.Liking for milk chocolate,34842,0.110967568074131,0.0462167913069247,0.0203826571125583,0.201552479035703,0.0163667994634831
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20692.Liking for mushrooms,34842,-0.0305942390412808,0.0478463321391677,-0.12437305003405,0.0631845719514879,0.522559265582689
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20694.Liking for orange juice,34842,0.180896817290341,0.0457611340881462,0.0912049944775745,0.270588640103108,7.7667693850926e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20695.Liking for oranges,34842,-0.130089960979544,0.0472536660561634,-0.222707146449624,-0.0374727755094636,0.00591521694113704
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20696.Liking for pasta,34842,-0.0141775479067766,0.0464594935573413,-0.105238155279166,0.0768830594656125,0.760250924222862
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20697.Liking for pears,34842,-0.0064136201428918,0.047119544253492,-0.0987679268797361,0.0859406865939524,0.891733958866631
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20698.Liking for pizza,34842,0.0169117572243974,0.0457132652261895,-0.0726862426189339,0.106509757067729,0.711425096068387
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20699.Liking for plain yogurt,34842,-0.121296097254824,0.0462359784077125,-0.21191861493394,-0.0306735795757071,0.00871808052025711
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20700.Liking for plums,34842,-0.135375201382499,0.0474171085504064,-0.228312734141296,-0.0424376686237028,0.00431239717127086
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20701.Liking for pollock,34842,-0.162390160642721,0.0454058928678623,-0.251385710663731,-0.0733946106217111,0.000349927407117819
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20702.Liking for pork chop,34842,0.0476234047107684,0.0454929595562845,-0.0415427960195491,0.136789605441086,0.29520226418881
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20703.Liking for porridge,34842,-0.045185869848477,0.0471921190914772,-0.137682423267772,0.0473106835708183,0.338343489190231
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20704.Liking for potato crisps,34842,0.0343721639181104,0.0460814432467721,-0.0559474648455629,0.124691792681784,0.455744512657466
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20705.Liking for potatoes,34842,0.196908407864311,0.0465893957245163,0.105593192244259,0.288223623484363,2.39422862132596e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20706.Liking for prawns,34842,-0.0958248875824766,0.0466377528996905,-0.18723488326587,-0.00441489189908317,0.0399364943099453
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20707.Liking for raw carrots,34842,-0.0801069743891918,0.0465980691789005,-0.171439189979837,0.0112252412014533,0.085625063450304
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20708.Liking for red meat,34842,0.106966116617326,0.0458353559636435,0.0171288189285848,0.196803414306067,0.0196302547530083
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20709.Liking for red wine,34842,-0.126566849434232,0.0458254788058747,-0.216384787893746,-0.0367489109747176,0.00575615121810595
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,34842,0.136387206177412,0.0485463741704579,0.0412363128033146,0.23153809955151,0.00497234958822146
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20711.Liking for roast chicken,34842,-0.0243402773771371,0.0486697578008797,-0.119733002666861,0.071052447912587,0.617007577846922
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20712.Liking for salad dressing,34842,0.0316751657511124,0.0459176581657648,-0.0583234442537865,0.121673775756011,0.490319429431298
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20713.Liking for salad leaves,34842,-0.105423796915614,0.047747162471486,-0.199008235359726,-0.0118393584715014,0.0272688835783084
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20714.Liking for salami,34842,-0.0831752036476399,0.0458067277705933,-0.172956390078003,0.00660598278272301,0.0694320794999433
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20715.Liking for salmon,34842,-0.117780011746517,0.0489963114700174,-0.213812782227751,-0.0217472412652829,0.0162406387974999
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20716.Liking for salty foods,34842,0.0470139166542607,0.0458106572337849,-0.0427749715239577,0.136802804832479,0.304790165235427
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20717.Liking for salty pretzels,34842,-0.0672947220906056,0.0456598539962093,-0.156788035923176,0.0221985917419646,0.140558519365938
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20718.Liking for sardines,34842,-0.22442278333307,0.0458865691327879,-0.314360458833334,-0.134485107832806,1.0192513468142e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20719.Liking for sausages (meat),34842,0.079440548996385,0.0454197937425339,-0.00958224673898143,0.168463344731751,0.0803155112902502
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20720.Liking for savoury biscuits,34842,0.140481861447146,0.0460021556607864,0.0503176363520052,0.230646086542288,0.00226527158077003
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),34842,-0.132193214735732,0.0457326723646676,-0.221829252570481,-0.0425571769009839,0.00385348464603431
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20722.Liking for skimmed milk,34842,-0.0979095735550967,0.0457357933256186,-0.187551728473309,-0.00826741863688427,0.0323162394653165
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20723.Liking for smoked fish,34842,-0.165417948015585,0.0458480413913497,-0.255280109142631,-0.0755557868885399,0.000310063393575754
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20724.Liking for soft cheese,34842,0.00816668439104888,0.045660855534194,-0.0813285924559714,0.0976619612380691,0.85805484041883
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20725.Liking for soy sauce,34842,-0.0130818742458903,0.045948301163517,-0.103140544526384,0.076976796034603,0.775873118059199
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20726.Liking for soya milk,34842,-0.100801809204509,0.0462189578724198,-0.191390966634452,-0.0102126517745662,0.029208565144574
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20727.Liking for spicy foods,34842,-0.0881831413035835,0.0460341765752925,-0.178410127391157,0.00204384478398978,0.0554432697283772
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20728.Liking for spinach,34842,-0.152538436178515,0.0464592314178246,-0.243598529757451,-0.0614783425995787,0.0010294787722445
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20729.Liking for spirits,34842,-0.0580934717712734,0.04570613005208,-0.14767748667335,0.0314905431308033,0.203749496918698
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20730.Liking for strawberries,34842,-0.0789660630073521,0.0522225121434102,-0.181322186808436,0.0233900607937319,0.130536904951039
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,34842,0.0329374791889374,0.0477410684124107,-0.0606350148993876,0.126509973277262,0.490260430493812
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20732.Liking for sweet foods,34842,0.0976589376692635,0.0457222884809406,0.00804325224662002,0.187274623091907,0.0327096407983637
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20733.Liking for taking the stairs,34842,-0.11024573411719,0.0465540522485141,-0.201491676524278,-0.0189997917101024,0.0178967931307528
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20734.Liking for tea with sugar,34842,0.108870733980343,0.0613211120575879,-0.0113186456525296,0.229060113613215,0.0758578414973378
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20735.Liking for tea without sugar,34842,-0.113316190279259,0.049425496643155,-0.210190163699842,-0.0164422168586749,0.0218871062114124
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20736.Liking for tomato ketchup,34842,0.0407790972680703,0.0456530692270497,-0.0487009184169471,0.130259112953088,0.371749957531407
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20737.Liking for tinned tuna,34842,-0.0934282227052537,0.0460591828589695,-0.183704221108834,-0.00315222430167358,0.0425409857997742
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20738.Liking for turnip (white),34842,0.00545360553247965,0.0458605727173476,-0.0844331169935217,0.095340328058481,0.905343348469598
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20739.Liking for vegetables,34842,-0.0678447213053376,0.0529609456048947,-0.171648174690931,0.035958732080256,0.200210676744044
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20740.Liking for vinegar,34842,0.0284949939736387,0.0460236845941334,-0.0617114278308627,0.11870141577814,0.535839296662062
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20741.Liking for watching television,34842,0.0731801648768128,0.04624868635964,-0.0174672603880816,0.163827590141707,0.113607279711686
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20742.Liking for whisky,34842,0.00950713049101468,0.0487754053355696,-0.0860926639667017,0.105106924948731,0.845462144111004
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20743.Liking for white bread,34842,0.158303522614076,0.0453981783325581,0.0693230930822624,0.24728395214589,0.000490489310802625
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20744.Liking for white rice,34842,0.0468661764014883,0.0459149557584724,-0.0431271368851176,0.136859489688094,0.30741231883422
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20745.Liking for white wine,34842,-0.0894877767957737,0.0459622807431344,-0.179573847052317,0.000598293460769658,0.0515637113755295
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,34842,-0.127074695864952,0.0461034133714485,-0.217437386072991,-0.0367120056569128,0.00585619492679566
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20747.Liking for whole milk,34842,0.090750817805401,0.0459210347954964,0.000745589606228073,0.180756046004574,0.0481544465040227
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20748.Liking for wholemeal bread,34842,-0.111015328887429,0.0482709798785238,-0.205626449449336,-0.0164042083255224,0.0214772676785908
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20749.Liking for working up a sweat,34842,-0.137502085137239,0.0459592666651982,-0.227582247801028,-0.0474219224734508,0.00277966807154869
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21001.Body mass index (BMI),51611,0.01931455272662,0.00914051476934176,0.00139914377871012,0.0372299616745298,0.0346038257058758
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21002.Weight,51619,-0.0246454037801978,0.0056450640294039,-0.0357097292778295,-0.0135810782825662,1.27107166546462e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33423,0.0199312560673317,0.0040631504710438,0.0119674811440859,0.0278950309905776,9.48906083900444e-07
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34255,0.0511756349673838,0.0476267565940962,-0.0421728079570448,0.144524077891812,0.282618662129074
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34269,0.0242368635224341,0.050141390405238,-0.0740402616718324,0.1225139887167,0.62884355086209
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34270,-0.0895335499586852,0.050099761654301,-0.187729082801115,0.00866198288374484,0.0739513181997275
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21040.Satisfaction with bowel habits,34224,-0.0174427490856544,0.0465527788097478,-0.10868619555276,0.0738006973814512,0.707900951599368
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34204,0.069939968291319,0.0484865355448053,-0.0250936413764994,0.164973577959137,0.149204326500898
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34219,0.0557845443144915,0.0499543397839663,-0.0421259616620825,0.153695050291065,0.264145526978143
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21043.Least number of times bowels opened per week,34129,0.0754974401620357,0.0494626769276639,-0.0214494066161856,0.172444286940257,0.126954988455943
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21044.Average number of times bowels opened per day,34183,0.133415357275939,0.0564099933123876,0.0228517703836593,0.243978944168219,0.0180446522371416
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34273,0.0215683904530275,0.0506933183223207,-0.077790513458721,0.120927294364776,0.670504785936215
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34267,-0.00470306111957575,0.0511575291365108,-0.104971818227137,0.0955656959879853,0.926753210863732
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34270,0.134269888266726,0.0596619334109738,0.0173324987812172,0.251207277752235,0.0244385160083084
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34270,0.0424640297682585,0.0528815912247083,-0.0611838890321697,0.146111948568687,0.421992950677925
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34268,-0.0183717926767981,0.078545941591712,-0.172321838196554,0.135578252842957,0.815068510134053
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34270,0.0280339125198868,0.05810354888075,-0.0858490432863833,0.141916868326157,0.629474388130591
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34270,0.111476827315499,0.147572576426582,-0.177765422480601,0.4007190771116,0.450025091576025
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34272,0.0843557342515992,0.0550568512277681,-0.0235556941548263,0.192267162658025,0.125515938756026
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34273,-0.206134323526707,0.0578898998897287,-0.319598527310575,-0.0926701197428388,0.000371476319908311
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34009,0.06345184027671,0.051764580395678,-0.0380067372988189,0.164910417852239,0.220312755460934
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34269,-0.0129114541185987,0.0519726441350684,-0.114777836623333,0.0889549283861354,0.803808556639312
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34272,-0.0462686767349878,0.0685626175433866,-0.180651407120025,0.0881140536500499,0.499794425912929
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34272,-0.0920793338192344,0.050479710853225,-0.191019567091555,0.00686089945308656,0.0681694504305693
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34270,-0.0511438671465157,0.0506122368781834,-0.150343851427755,0.0480561171347238,0.312278795332261
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X21100.Water hardness (USGS classification),51479,-0.00621372706194573,0.0301100956678085,-0.0652295145708504,0.0528020604469589,0.836505879926776
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2139.Age first had sexual intercourse,47858,-0.00139706878652797,0.00287911349404318,-0.0070401312348526,0.00424599366179665,0.627508742251621
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2149.Lifetime number of sexual partners,46364,-0.076048854324166,0.0337558280228045,-0.142210277248863,-0.00988743139946921,0.0242746518420909
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22032.IPAQ activity group,45478,-0.113379410055019,0.0339997607661541,-0.180018941156681,-0.0467398789533573,0.000855354247977768
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22033.Summed days activity,46151,-0.012732265953753,0.00272068804831636,-0.0180648145284531,-0.00739971737905299,2.88893442780664e-06
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22034.Summed minutes activity,45478,-0.00707663828313984,0.00273678462643616,-0.0124407361509547,-0.00171254041532497,0.00972342637647534
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22037.MET minutes per week for walking,44452,-0.00407538709623115,0.00278004694356086,-0.00952427910561044,0.00137350491314814,0.142679856839189
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22038.MET minutes per week for moderate activity,45478,-0.00725107643861929,0.00270380660761156,-0.012550537389538,-0.00195161548770062,0.0073283771164666
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22039.MET minutes per week for vigorous activity,45478,-0.203443113110718,0.0341358531537203,-0.27034938529201,-0.136536840929426,2.56561845729462e-09
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22040.Summed MET minutes per week for all activity,44452,-0.010581725646481,0.00283297760521645,-0.0161343617527052,-0.00502908954025675,0.000188090120141755
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X2217.Age started wearing glasses or contact lenses,47872,0.000574857620097496,0.00260790071956806,-0.00453662779025591,0.0056863430304509,0.825538782662033
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X22501.Year ended full time education,31224,-0.0204080344910392,0.0121568034294771,-0.0442353692128143,0.00341930023073595,0.0932501088989849
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X22506.Tobacco smoking,31179,-0.0310876934792487,0.126496971613225,-0.27902175784117,0.216846370882672,0.805876760380357
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49860,-0.0146519392983155,0.0711921197264588,-0.154188493962175,0.124884615365544,0.836942194951711
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23098.Weight,51201,-0.0241238628791466,0.00568364750062824,-0.035263811980378,-0.0129839137779153,2.19884549048006e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23099.Body fat percentage,51202,0.0328561330216868,0.00583338648982641,0.021422695501627,0.0442895705417466,1.7947226505385e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23100.Whole body fat mass,51193,0.0137955146547926,0.00559623013771111,0.00282690358487881,0.0247641257247064,0.0137020444401696
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23101.Whole body fat-free mass,51201,-0.0381292917461584,0.00467101955943078,-0.0472844900826427,-0.0289740934096741,3.4119479120541e-16
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23102.Whole body water mass,51201,-0.0377444786416986,0.00468798921823733,-0.0469329375094438,-0.0285560197739534,8.52869622584324e-16
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23104.Body mass index (BMI),51201,0.0235112624209612,0.00925110854336723,0.00537908967596144,0.041643435165961,0.0110448574738009
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23105.Basal metabolic rate,51199,-0.0393909955711407,0.00509432396528782,-0.0493758705431048,-0.0294061205991766,1.09298955357401e-14
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23106.Impedance of whole body,51195,0.0271837789777864,0.00382125541697568,0.0196941183605141,0.0346734395950588,1.15701961957819e-12
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23107.Impedance of leg (right),51198,0.0353406285028022,0.00311688765624907,0.029231528696554,0.0414497283090504,9.89726001836816e-30
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23108.Impedance of leg (left),51197,0.0310145108795819,0.00308820121221698,0.0249616365036366,0.0370673852555272,1.08749338035525e-23
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23109.Impedance of arm (right),51188,0.0129487581903919,0.00383208488544728,0.00543787181491522,0.0204596445658686,0.000728439694595943
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23110.Impedance of arm (left),51196,0.0106521519299159,0.00384482544209027,0.00311629406341902,0.0181880097964129,0.00560061031135232
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23111.Leg fat percentage (right),51197,0.098086950879009,0.00917553690504979,0.0801028985451114,0.116071003212907,1.28248772571716e-26
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23112.Leg fat mass (right),51196,0.0536997866749445,0.0105666028036322,0.0329892451798253,0.0744103281700637,3.75936411795519e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23113.Leg fat-free mass (right),51196,-0.048206784778521,0.00474199999418904,-0.0575011047671315,-0.0389124647899105,3.11525718578338e-24
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23114.Leg predicted mass (right),51195,-0.0480345034166009,0.00475951438479877,-0.0573631516108065,-0.0387058552223953,6.59385855071525e-24
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23115.Leg fat percentage (left),51192,0.0878931335344923,0.00947448577957094,0.0693231414065333,0.106463125662451,1.87396332733366e-20
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23116.Leg fat mass (left),51192,0.0432842937218796,0.0106056397591149,0.0224972397940145,0.0640713476497447,4.49236581523223e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23117.Leg fat-free mass (left),51190,-0.0444677084521818,0.00486805373636927,-0.0540090937754655,-0.034926323128898,7.01659997481325e-20
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23118.Leg predicted mass (left),51189,-0.0448741653523278,0.00488582389486078,-0.0544503801862549,-0.0352979505184007,4.42253882440004e-20
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23119.Arm fat percentage (right),51189,0.0282443854301243,0.0065035463122105,0.0154974346581917,0.0409913362020569,1.4111800308827e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23120.Arm fat mass (right),51185,0.0121716629539066,0.00584796834409061,0.000709644999488977,0.0236336809083242,0.0374114677036201
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23121.Arm fat-free mass (right),51187,-0.0265172630378263,0.00454779042778078,-0.0354309322762766,-0.017603593799376,5.5795759565901e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23122.Arm predicted mass (right),51186,-0.0276716393792359,0.00454514532918828,-0.0365801242244449,-0.0187631545340268,1.15759766162673e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23123.Arm fat percentage (left),51183,0.0304029815024776,0.00730114467614995,0.0160927379372237,0.0447132250677315,3.13509002552853e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23124.Arm fat mass (left),51182,0.012999102315776,0.00599859592577114,0.00124185430126459,0.0247563503302875,0.0302418142640656
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23125.Arm fat-free mass (left),51182,-0.0273588517372143,0.00490463766628008,-0.0369719415631233,-0.0177457619113053,2.45426887446723e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23126.Arm predicted mass (left),51180,-0.026089263285732,0.0049097275688047,-0.0357123293205892,-0.0164661972508748,1.08227558118134e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23127.Trunk fat percentage,51178,0.0138049866506371,0.00368997637149489,0.00657263296250713,0.0210373403387671,0.000183517163872504
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23128.Trunk fat mass,51175,0.00786755889004831,0.00425230981946379,-0.00046696835610071,0.0162020861361973,0.0642979533977054
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23129.Trunk fat-free mass,51169,-0.028959724321794,0.00436277772122647,-0.0375107686553979,-0.0204086799881901,3.24253614494099e-11
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23130.Trunk predicted mass,51166,-0.0290949476990632,0.00436975779973422,-0.0376596729865423,-0.0205302224115841,2.824736893255e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23400.Total Cholesterol,40042,0.0247721472676426,0.0032443879612488,0.0184131468635949,0.0311311476716902,2.38168969952263e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40042,0.0376192535336861,0.00313103699234633,0.0314824210286873,0.0437560860386849,4.15272771807904e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40042,0.0397536645018076,0.00312334161006544,0.0336319149460793,0.0458754140575358,6.31559092125506e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23403.VLDL Cholesterol,40042,0.0513610280496426,0.00305140584320879,0.0453802725969534,0.0573417835023318,5.12551883491326e-63
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40042,0.0305270462317563,0.00313898734715279,0.0243746310313368,0.0366794614321757,2.72617575990942e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23405.LDL Cholesterol,40042,0.0343358396075241,0.00313579620250373,0.0281896790506168,0.0404820001644314,8.4229079468835e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23406.HDL Cholesterol,40042,-0.0381187394981858,0.00361551902686256,-0.0452051567908364,-0.0310323222055352,6.68269226016932e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23407.Total Triglycerides,40042,0.0660441587190069,0.00328816357095733,0.0595993581199305,0.0724889593180832,1.30417366087993e-88
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23408.Triglycerides in VLDL,40042,0.0642748859293843,0.00329261567027186,0.0578213592156514,0.0707284126431171,7.29731821389033e-84
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23409.Triglycerides in LDL,40042,0.0618874366250689,0.00327871094827932,0.0554611631664414,0.0683137100836964,1.36150369610156e-78
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23410.Triglycerides in HDL,40042,0.0534122655322103,0.00310651228716823,0.0473235014493606,0.0595010296150601,1.19359895789871e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40042,0.0266487604374878,0.00330266033489717,0.0201755461810894,0.0331219746938863,7.60808976785255e-16
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23412.Phospholipids in VLDL,40042,0.0599723243751953,0.00313333742311833,0.0538309830258834,0.0661136657245072,9.85914643784998e-81
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23413.Phospholipids in LDL,40042,0.0356792628874134,0.00311126013719708,0.0295811930185071,0.0417773327563197,2.53370186592141e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23414.Phospholipids in HDL,40042,-0.0204719496025336,0.00351404504807969,-0.0273594778967698,-0.0135844213082974,5.79772021802653e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23415.Total Esterified Cholesterol,40042,0.0220145347191279,0.00325633590393938,0.0156321163474067,0.0283969530908491,1.42374990009332e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40042,0.0467344621330667,0.00303821962456749,0.0407795516689144,0.052689372597219,5.28195149232706e-53
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40042,0.0378709979437746,0.00312689478743498,0.031742284160402,0.0439997117271472,1.30149203333273e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40042,-0.0405084911678588,0.00359061259267552,-0.0475460918495028,-0.0334708904862148,2.09898822997879e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23419.Total Free Cholesterol,40042,0.0310094348254582,0.00321292817506526,0.0247120956023303,0.0373067740485861,5.58321984020309e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40042,0.0570296192137623,0.0030996990047608,0.0509542091644311,0.0631050292630935,8.36158502212473e-75
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23421.Free Cholesterol in LDL,40042,0.0236915089461502,0.00316834040100952,0.0174815617601715,0.0299014561321288,7.97296551253612e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23422.Free Cholesterol in HDL,40042,-0.0276048051254056,0.00363234509309366,-0.0347242015078692,-0.0204854087429421,3.13613187939198e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40042,0.0410996253863489,0.00321849742593742,0.0347913704315116,0.0474078803411863,3.71085344845517e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23424.Total Lipids in VLDL,40042,0.0626192377472951,0.00319480103119526,0.0563574277261523,0.0688810477684378,1.59513563448342e-84
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23425.Total Lipids in LDL,40042,0.0371923404406882,0.00312697544745056,0.0310634685636851,0.0433212123176913,1.75676255365665e-32
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23426.Total Lipids in HDL,40042,-0.02422018181075,0.00355532423537563,-0.0311886173120862,-0.0172517463094137,9.95175160617595e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40042,0.00575998360997528,0.00333218650468523,-0.000771101939207768,0.0122910691591583,0.0839023350927859
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23428.Concentration of VLDL Particles,40042,0.0561247432790688,0.00309117443793875,0.0500660413807088,0.0621834451774287,6.43371114344086e-73
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23429.Concentration of LDL Particles,40042,0.0387856991834666,0.00310098182332487,0.0327077748097499,0.0448636235571833,1.00744910927691e-35
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23430.Concentration of HDL Particles,40042,-0.00142218967888426,0.00334017424156383,-0.00796893119234937,0.00512455183458085,0.670271794345547
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40042,0.0632687910629321,0.00347887500763429,0.0564501960479688,0.0700873860778953,3.75830345576108e-73
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40042,-0.0308783795352218,0.00320472047012342,-0.0371596316566637,-0.0245971274137799,6.53036782152427e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40042,-0.0593588792502582,0.00377520731798966,-0.0667582855935179,-0.0519594729069984,2.78208160369455e-55
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23434.Phosphoglycerides,40028,0.0224304192487116,0.00332116427841594,0.0159209372630164,0.0289399012344069,1.49137720663829e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40028,0.0674692283993482,0.00348767251416034,0.0606333902715939,0.0743050665271024,2.07461227658111e-82
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23436.Total Cholines,40028,0.0206180508975916,0.00333010263607099,0.0140910497308924,0.0271450520642907,6.1121022473385e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23437.Phosphatidylcholines,40028,0.0191732360555662,0.00333256064666641,0.0126414171881,0.0257050549230323,8.91594954116976e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23438.Sphingomyelins,40027,0.0123203256177059,0.00335297436556382,0.00574849586120086,0.018892155374211,0.000239164699416899
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23439.Apolipoprotein B,40042,0.039952311459009,0.00309847026893027,0.0338793097319056,0.0460253131861123,7.57542636314524e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23440.Apolipoprotein A1,40042,-0.0127507021728458,0.00345061108467405,-0.0195138998988069,-0.00598750444688462,0.000220464538312265
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40042,0.0407995724888948,0.00312952083236716,0.0346657116574552,0.0469334333203344,1.20013355878674e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23442.Total Fatty Acids,40028,0.0506403574061197,0.00330747002592503,0.0441577161553067,0.0571229986569328,1.56000758298505e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23443.Degree of Unsaturation,40028,-0.0805894329437658,0.00343940652444617,-0.0873306697316804,-0.0738481961558513,2.36272771482241e-119
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40028,-0.025420857965946,0.00326263332289766,-0.0318156192788254,-0.0190260966530666,7.03698268796516e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40028,0.0359587112150686,0.00320941414796042,0.0296682594850661,0.042249162945071,5.02451592410401e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40028,0.0241337283045155,0.00324402708172168,0.017775435224341,0.03049202138469,1.06387098477507e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40028,0.0675956549279009,0.00337750827123324,0.0609757387162838,0.0742155711395181,5.35322765992783e-88
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23448.Saturated Fatty Acids,40028,0.0554058375887689,0.00337399420865131,0.0487928089398123,0.0620188662377254,4.29588949115889e-60
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23449.Linoleic Acid,40028,0.0409062292315556,0.00317365817727365,0.0346858592040993,0.047126599259012,8.07086631982313e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23450.Docosahexaenoic Acid,40028,-0.0447402375065724,0.00341701955495129,-0.0514375958342769,-0.0380428791788679,5.77186960625736e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40028,-0.0588006899951578,0.00323387448281724,-0.0651390839814796,-0.052462296008836,4.03053086485708e-73
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40028,-0.0493468999674446,0.0036239847013559,-0.0564499099821021,-0.042243889952787,5.5375495303387e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40028,-0.0818392539868075,0.00360396803573017,-0.0889030313368386,-0.0747754766367763,2.46562855648247e-112
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40028,0.0796301963170779,0.00355091115506918,0.0726704104531423,0.0865899821810135,1.20541559209486e-109
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40028,0.0374232359214249,0.00338791757528049,0.0307829174738752,0.0440635543689747,2.91553057107263e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40028,-0.00840910551250718,0.00350726839983081,-0.0152833515761756,-0.00153485944883878,0.0165135634555699
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40028,-0.0803719031687727,0.00342237424560391,-0.0870797566901564,-0.0736640496473891,7.08695470619914e-120
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40028,-0.0846603302631985,0.00358339616510275,-0.0916837867467999,-0.0776368737795971,2.82167231090598e-121
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40026,0.0436032049701362,0.00323524288977196,0.0372621289061832,0.0499442810340893,3.60625718553136e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23460.Alanine,40035,0.0153991730531545,0.00310872340279473,0.00930607518367679,0.0214922709226321,7.36405327140249e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23461.Glutamine,39992,-0.00767972871354496,0.00314103252050956,-0.0138361524537437,-0.00152330497334623,0.0144974648883971
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23462.Glycine,40021,-0.00415894343842977,0.00299940442460522,-0.010037776110656,0.00171988923379646,0.165586748533984
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23463.Histidine,40022,-0.00403905951304516,0.00306494727420893,-0.0100463561704947,0.00196823714440435,0.187582131446866
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40032,0.0193106321562939,0.00312455715559466,0.0131865001313283,0.0254347641812594,6.55813127871309e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23465.Isoleucine,40038,0.0121968992474396,0.00307172371591119,0.00617632076425365,0.0182174777306255,7.19829261993584e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23466.Leucine,40039,0.018453889455049,0.00312644786316046,0.0123260516432545,0.0245817272668435,3.65443164528066e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23467.Valine,40032,0.0206853901184351,0.00314961934157648,0.0145121362089452,0.026858644027925,5.27570441210378e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23468.Phenylalanine,40039,0.00507787474956831,0.00305132709847493,-0.000902726363442561,0.0110584758625792,0.0961019844593666
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23469.Tyrosine,40023,0.00790409050830795,0.00307272246910843,0.00188155446885543,0.0139266265477605,0.0101105106572386
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23470.Glucose,40009,0.00137810687719195,0.00325215825189861,-0.00499612329652933,0.00775233705091322,0.671752924296106
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23471.Lactate,40009,0.0297478074134146,0.00304051710734102,0.0237883938830262,0.035707220943803,1.53495986148533e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23472.Pyruvate,39994,0.00739823358527804,0.00315040000465104,0.00122344957616199,0.0135730175943941,0.0188693870179941
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23473.Citrate,40040,0.0173911949401917,0.00312685405637451,0.0112625609896977,0.0235198288906858,2.71267277716181e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23474.3-Hydroxybutyrate,39849,0.0128012044351697,0.00293915777924413,0.00704045518785125,0.0185619536824882,1.33683288118977e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23475.Acetate,40028,-0.0287214578102097,0.0031615581768772,-0.034918111836889,-0.0225248037835304,1.1637625045293e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23476.Acetoacetate,40041,0.00507773024843332,0.00305244873519948,-0.000905069272557665,0.0110605297694243,0.0962336854368245
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23477.Acetone,40041,-0.0130229910840217,0.00306098818168599,-0.0190225279201263,-0.00702345424791719,2.10734303786136e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23478.Creatinine,39565,0.0184569458290018,0.00359891671513142,0.0114030690673442,0.0255108225906594,2.95713439216856e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23479.Albumin,40041,0.000639923584970033,0.00317094414241248,-0.00557512693415842,0.00685497410409849,0.840069043831189
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23480.Glycoprotein Acetyls,40042,0.0659962544626414,0.00333364267206774,0.0594623148253886,0.0725301940998942,3.60431579734883e-86
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40042,0.0603014551551996,0.00332727415119141,0.0537799978188644,0.0668229124915347,1.1596961854242e-72
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40042,0.0573003755727446,0.00333264199258708,0.0507683972672739,0.0638323538782153,1.1928930682842e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40042,0.0602231996115122,0.00327476523156094,0.0538046597576528,0.0666417394653716,9.72336321771772e-75
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40042,0.0628784989151471,0.00326880590453427,0.0564716393422599,0.0692853584880343,1.62728326975092e-81
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40042,0.0635592278541526,0.00324919620653304,0.0571908032893479,0.0699276524189574,3.35687728469563e-84
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40042,0.0596901009699034,0.00328742475789879,0.0532467484444217,0.066133453495385,6.35913105667321e-73
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40042,0.052421860321738,0.00336120799166507,0.0458338926580744,0.0590098279854015,1.99313586401877e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40042,0.0668092719851014,0.00325706907575343,0.0604254165966247,0.0731931273735782,2.76739024258145e-92
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40042,0.065244254961702,0.00326676920117481,0.0588413873273994,0.0716471225960046,1.19863854385376e-87
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40042,0.0649229518725699,0.00323706469161635,0.0585783050770018,0.0712675986681379,2.31719342556953e-88
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40042,0.0625268998481938,0.00314786480701601,0.0563570848264424,0.0686967148699451,9.97768676531355e-87
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40042,0.0599012039653048,0.00308623490628369,0.0538521835489887,0.0659502243816208,6.13757798248952e-83
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40042,0.0632512552812316,0.00321611815510574,0.0569476636972244,0.0695548468652388,4.43796642083309e-85
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40042,0.0638768522653325,0.00330794374950099,0.0573932825163106,0.0703604220143544,4.00957487697097e-82
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40042,0.0656234886283454,0.0032285526158041,0.0592955255013693,0.0719514517553214,1.13052030838893e-90
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40042,0.0634515466887071,0.00322523326997855,0.0571300894795491,0.069773003897865,3.9147541046971e-85
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40042,0.0657125291055943,0.00320433053864341,0.0594320412498532,0.0719930169613354,3.03860382530938e-92
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40042,0.0615543413500606,0.00311649191227837,0.055446017201995,0.0676626654981262,8.75247999256219e-86
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40042,0.0568617942939593,0.00304667850975488,0.0508903044148397,0.0628332841730789,6.74127813760589e-77
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40042,0.0654171795108319,0.00319319531767277,0.0591585166881933,0.0716758423334705,4.62345512608461e-92
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40042,0.0604472205048727,0.00328039783935161,0.0540176407397436,0.0668768002700019,5.0084193933999e-75
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40042,0.0515498651707398,0.00307755691247687,0.0455178536222851,0.0575818767191944,1.98042923909064e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40042,0.0547536527150658,0.00310709806816589,0.0486637405014607,0.060843564928671,7.74243105821698e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40042,0.0499170435835342,0.00307163090400482,0.0438966470116848,0.0559374401553837,6.69817870396204e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40042,0.0342686923959369,0.00310864054119632,0.0281757569351921,0.0403616278566816,3.73240546972366e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40042,0.0245126364192066,0.0031669821374842,0.0183053514297376,0.0307199214086756,1.05440602726274e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40042,0.0450530034320952,0.00306821282500786,0.0390393062950798,0.0510667005691107,1.72567123491237e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40042,0.0617068666327753,0.00321695252740391,0.0554016396790636,0.0680120935864869,4.50723206209623e-81
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40042,0.0592915050496614,0.00309130495624574,0.0532325473354198,0.0653504627639031,4.65246944576877e-81
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40042,0.0584900844209373,0.00307456345048019,0.0524639400579961,0.0645162287838785,8.65967423790583e-80
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40042,0.0514710915021789,0.00304693018136191,0.0454991083467096,0.0574430746576483,1.86463041012864e-63
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40042,0.0493047583061229,0.00301429595914865,0.0433967382261916,0.0552127783860543,1.2171536845574e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40042,0.0512395827785936,0.00299406655258344,0.04537121233553,0.0571079532216571,4.6057008766773e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40042,0.0449596281288113,0.00305968882640256,0.0389626380290623,0.0509566182285603,1.48348437361419e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40042,0.0608014796336715,0.00318690703706256,0.0545551418410289,0.0670478174263141,3.12146932696455e-80
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40042,0.0416686120544004,0.00312892101187132,0.0355359268711326,0.0478012972376682,3.04861062467828e-40
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40042,0.0399913284785212,0.00312841145388722,0.0338596420289023,0.0461230149281402,3.12720212978236e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40042,0.0407241589365764,0.00312234860638208,0.0346043556680676,0.0468439622050853,1.11322457393375e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40042,0.0280215100499775,0.003194374207236,0.021760536603795,0.0342824834961601,1.93169547184174e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40042,0.0233477370453258,0.00322058128107044,0.0170353977344277,0.0296600763562238,4.3781107908075e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40042,0.0376633392070063,0.00313985429866854,0.0315092247816159,0.0438174536323966,5.25772540687382e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40042,0.0550630069657032,0.00316918991851872,0.0488513947254065,0.0612746192059999,5.50268907317364e-67
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23523.Concentration of IDL Particles,40042,0.0291095835841241,0.00314888542680653,0.0229377681475833,0.0352813990206649,2.66545738265596e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23524.Total Lipids in IDL,40042,0.0236294928435042,0.00323717237119655,0.017284634995959,0.0299743506910495,3.02944550111821e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23525.Phospholipids in IDL,40042,0.0233977510241893,0.00324852301464312,0.0170306459154888,0.0297648561328898,6.1784644895282e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23526.Cholesterol in IDL,40042,0.018304297113513,0.00324314612369556,0.0119477307110697,0.0246608635159563,1.69042151442392e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40042,0.0183123055796016,0.00323490392442881,0.0119718938877212,0.0246527172714821,1.53277918040209e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23528.Free Cholesterol in IDL,40042,0.0177599716970285,0.00326309763917691,0.0113643003242418,0.0241556430698153,5.32798260260386e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23529.Triglycerides in IDL,40042,0.0524086054143251,0.00321685049129478,0.0461035784513873,0.0587136323772629,3.47238359938048e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40042,0.0331571378770433,0.00311980343811353,0.0270423231383408,0.0392719526157458,2.71756114765532e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23531.Total Lipids in Large LDL,40042,0.0321633630892645,0.00315533360072858,0.0259789092318365,0.0383478169466925,2.53139522503613e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23532.Phospholipids in Large LDL,40042,0.0320854081654144,0.00314015518530884,0.0259307040022091,0.0382401123286198,1.97113103578027e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23533.Cholesterol in Large LDL,40042,0.0287481400385213,0.00316740450013939,0.0225400272182481,0.0349562528587945,1.25586051341242e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40042,0.0311673000299986,0.00315306181657367,0.0249872988695142,0.037347301190483,5.66260983284088e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40042,0.0212658283371418,0.0032038724002769,0.0149862384325991,0.0275454182416846,3.29488380210404e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23536.Triglycerides in Large LDL,40042,0.0582107985346552,0.0032562571048009,0.0518285346092454,0.064593062460065,9.12085126439732e-71
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40042,0.0462134087159265,0.00308709483204932,0.0401627028451099,0.0522641145867432,2.58391382675748e-50
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40042,0.0459427035647974,0.00310066918189064,0.0398653919682917,0.052020015161303,2.46244130768917e-49
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40042,0.0429943597479334,0.00308158314530113,0.0369544567831431,0.0490342627127236,5.62044974529466e-44
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40042,0.0441172539697817,0.00310241561977207,0.0380365193550284,0.0501979885845349,1.32205374949404e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40042,0.0488274211632295,0.00310844403686258,0.0427348708509788,0.0549199714754801,3.53108554256268e-55
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40042,0.0294000767700572,0.00311582980455925,0.023293050353121,0.0355071031869933,4.42019080380263e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40042,0.0654332635506428,0.00329656767434757,0.0589719909089215,0.071894536192364,1.31877818665134e-86
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40042,0.0440157338430014,0.00307809715897117,0.0379826634114179,0.0500488042745849,4.30229867609653e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23545.Total Lipids in Small LDL,40042,0.0410307060069747,0.00310945373609549,0.0349361766842275,0.0471252353297218,1.51799416586439e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23546.Phospholipids in Small LDL,40042,0.0309706483182711,0.00310079978259982,0.0248930807443754,0.0370482158921667,2.02377570371757e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23547.Cholesterol in Small LDL,40042,0.0402322524284549,0.00310230664387296,0.0341517314064639,0.0463127734504459,2.91188996345013e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40042,0.0465334704861452,0.0031160940909727,0.0404259260678387,0.0526410149044517,4.44246399128305e-50
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40042,0.0212194380437407,0.00309960521559238,0.0151442118211797,0.0272946642663018,7.8859074293652e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23550.Triglycerides in Small LDL,40042,0.0661129831018925,0.00332435459588253,0.0595972480939627,0.0726287181098223,6.23547021164427e-87
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40042,-0.0391446977121991,0.00359540382729366,-0.0461916892136947,-0.0320977062107035,1.66204694658522e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40042,-0.0505813418809586,0.00361211975192025,-0.0576610965947223,-0.0435015871671949,2.76247496861978e-44
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40042,-0.0532630390476354,0.00361333498860504,-0.0603451756253013,-0.0461809024699696,7.52971376976124e-49
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40042,-0.0515482714990207,0.00358654119645185,-0.0585778922440663,-0.044518650753975,1.52298855812161e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40042,-0.0539554053848336,0.00364292393596154,-0.0610955362993182,-0.0468152744703489,2.68956560844395e-49
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40042,-0.0401880872193133,0.00334883607382435,-0.0467518059240091,-0.0336243685146176,4.93083032041052e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40042,0.0400011087064154,0.00323586261461931,0.0336588179817616,0.0463433994310693,6.13130308190297e-35
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40042,-0.0522611624230241,0.00380294033056666,-0.0597149254709347,-0.0448073993751134,1.00497210043327e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23559.Total Lipids in Large HDL,40042,-0.0540581956877797,0.00378182661872329,-0.0614705758604773,-0.046645815515082,4.64827552584702e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23560.Phospholipids in Large HDL,40042,-0.0516118919945285,0.00373450684028823,-0.0589315254014934,-0.0442922585875636,3.45726656284525e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23561.Cholesterol in Large HDL,40042,-0.0598394591772671,0.00377591309622626,-0.0672402488458706,-0.0524386695086637,3.99986648906213e-56
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40042,-0.0611889064544062,0.00376436915329388,-0.0685670699948622,-0.0538107429139502,6.30539044409862e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40042,-0.0538404150679129,0.00377471682144024,-0.0612388600379358,-0.0464419700978901,7.18721776312464e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23564.Triglycerides in Large HDL,40042,0.0272443213959427,0.00320570682723677,0.0209611360145587,0.0335275067773268,2.08891205397495e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40042,-0.0154753104751628,0.00342263392550517,-0.0221836729691529,-0.00876694798117261,6.18663176318863e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40042,-0.0120629806932987,0.00339252607200205,-0.0187123317944227,-0.00541362959217466,0.000378016191016225
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40042,-0.00779051621960557,0.00337136450182125,-0.0143983906431752,-0.00118264179603593,0.0208574269539766
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40042,-0.0252790222434333,0.00343105787365615,-0.0320038956757994,-0.0185541488110673,1.82283880435986e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40042,-0.0267200163542573,0.00341358508454376,-0.0334106431199631,-0.0200293895885515,5.2927239061837e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40042,-0.0184944080543484,0.00347497718296114,-0.0253053633329523,-0.0116834527757446,1.03957704421771e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40042,0.0506988994986118,0.00308129407942243,0.0446595631029438,0.0567382358942797,2.540419484292e-60
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40042,0.0314744897802302,0.00307152322731149,0.0254543042546997,0.0374946753057607,1.4576531401172e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23573.Total Lipids in Small HDL,40042,0.03540167620405,0.0031013883658465,0.0293229550069909,0.0414803974011092,4.64395798644179e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23574.Phospholipids in Small HDL,40042,0.0326308107913652,0.00313629921202529,0.0264836643357957,0.0387779572469348,2.86899955050651e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23575.Cholesterol in Small HDL,40042,0.0244844347044155,0.00308194765333647,0.018443817303876,0.0305250521049549,2.08271906314699e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40042,0.020867054128827,0.003049133854859,0.0148907517733033,0.0268433564843506,8.01052029153244e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40042,0.0321123165221579,0.00318898075982515,0.0258619142329006,0.0383627188114152,8.88444979949657e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23578.Triglycerides in Small HDL,40042,0.0673867166354545,0.0031650528879792,0.0611832129750152,0.0735902202958937,3.54687845055823e-99
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,0.0223527704175165,0.00291979117640669,0.0166299797117594,0.0280755611232736,2.04319789382841e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,-0.000816406540182013,0.00307026147992031,-0.00683411904082581,0.00520130596046179,0.790313921820677
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,0.00662791405054996,0.00299623700549071,0.000755289519788176,0.0125005385813117,0.0269764628275929
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,-0.0132615378111051,0.00312644566865393,-0.0193893713216668,-0.00713370430054339,2.23157723101746e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,-0.00822900672541925,0.00297399433948729,-0.0140580356308143,-0.00239997782002417,0.00566473780011378
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39810,0.0242274816273687,0.00287511807353145,0.0185922502032471,0.0298627130514904,3.87068099163648e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39810,-0.0320076035010806,0.00326229756077246,-0.0384017067201946,-0.0256135002819666,1.17263816580365e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39810,-0.0330459602531068,0.00326997511347461,-0.0394551114755171,-0.0266368090306966,6.18143502152798e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39810,-0.0193538731140463,0.00309879715253188,-0.0254275155330088,-0.0132802306950838,4.33266021599065e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39810,0.0181826864859938,0.00313491453194933,0.0120382540033731,0.0243271189686145,6.75956922670141e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40037,0.0544487021946773,0.00303958287672716,0.048491119756292,0.0604062846330625,4.79231085766816e-71
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40037,-0.00192432118532478,0.00303052438399162,-0.00786414897794836,0.0040155066072988,0.525451036433509
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40037,-0.0163708768864062,0.00317947900310237,-0.0226026557324868,-0.0101390980403255,2.65182464160411e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40037,0.0286895018410518,0.00290480356817314,0.0229960868474324,0.0343829168346711,6.14272490715569e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40037,-0.0216548224886677,0.00285704409619943,-0.0272546289172186,-0.0160550160601169,3.6651068892997e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40042,-0.0059753014942923,0.00320271069343498,-0.0122526144534249,0.000302011464840264,0.0621019347554474
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40042,-0.0343253458452725,0.00333616231505668,-0.0408642239827836,-0.0277864677077614,9.49121407833856e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40042,-0.0388599635877166,0.00335764466197998,-0.0454409471251974,-0.0322789800502359,7.49903216380436e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40042,-0.0199358944539035,0.00326952159763374,-0.0263441567852656,-0.0135276321225413,1.10283807062435e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40042,0.0284080344773663,0.00331593895672417,0.0219087941221869,0.0349072748325456,1.15921395232115e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40042,-0.028129499582877,0.00324909554317676,-0.0344977268475034,-0.0217612723182505,5.28144007409693e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40042,-0.0119207283199327,0.00318879454839806,-0.0181707656347929,-0.00567069100507251,0.000185917630296903
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40042,0.00139504582030189,0.00310279535661205,-0.00468643307865774,0.00747652471926151,0.652998391812743
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40042,-0.0282297349437852,0.00325990714784548,-0.0346191529535623,-0.021840316934008,5.18846998504972e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40042,0.017173376071834,0.0032126582265677,0.0108765659477613,0.0234701861959067,9.14197385362296e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40042,0.0134421900341698,0.00327061019473482,0.00703179405248959,0.0198525860158501,3.97692777541183e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40042,-0.0335879163382872,0.00338629650848796,-0.0402250574949236,-0.0269507751816508,4.03882132914559e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40042,-0.0366175763529974,0.0034057933456522,-0.0432929313104757,-0.0299422213955191,7.23850835615557e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40042,-0.00402243519335495,0.00331782216325496,-0.0105253666333347,0.00248049624662479,0.225388328355505
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40042,0.0349032829118267,0.0033806551355666,0.0282771988461162,0.0415293669775373,6.57425425756548e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40042,-0.00711353516315171,0.00305231660024398,-0.0130960756996299,-0.00113099462667352,0.0197905036111624
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40042,-0.0193466042421266,0.00322412542238373,-0.0256658900699988,-0.0130273184142545,2.00974097126033e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40042,-0.0150730104640395,0.0032130805297472,-0.0213706483023441,-0.00877537262573504,2.73993196365736e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40042,-0.0180300010221852,0.00331494801016378,-0.0245272991221062,-0.0115327029222642,5.43876760731951e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40042,0.0306310644743606,0.00332729705918283,0.0241095622383623,0.037152566710359,3.80728896801702e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40042,-0.0031703688182175,0.00303789843277942,-0.00912464974646517,0.00278391211003017,0.296683930166234
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40042,-0.0259551940148297,0.00334196785496997,-0.0325054510105709,-0.0194049370190886,8.57234823857364e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40042,0.00588597393773745,0.00308687697239602,-0.000164304928158751,0.0119362528036336,0.0565683415372363
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40042,-0.04046909102261,0.00332530088455583,-0.0469866807563395,-0.0339515012888806,6.39585722061522e-34
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40042,0.0258102685912467,0.00331967383482019,0.0193037078749991,0.0323168293074943,8.01795658436941e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40042,-0.0290473427510159,0.00299927329199846,-0.0349259184033329,-0.0231687670986989,4.0390795551343e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40042,0.00183512547156476,0.00309878742602615,-0.0042384978834465,0.00790874882657602,0.553720167647161
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40042,0.0443326559010538,0.00311845177909386,0.0382204904140298,0.0504448213880778,1.39982079552278e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40042,-0.0566214887138962,0.00337295723932234,-0.063232484902968,-0.0500104925248244,1.08072366060518e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40042,0.0175635699470996,0.0032087466412168,0.0112744265303147,0.0238527133638846,4.47656041726516e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40042,-0.0502640140437565,0.00304593723247714,-0.0562340510194118,-0.0442939770681013,1.16015158513241e-60
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40042,0.0199176822206327,0.00310794160914265,0.0138261166667131,0.0260092477745523,1.51037436622952e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40042,0.0503079662107324,0.00307356006610133,0.0442837884811738,0.056332143940291,1.01899778932121e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40042,-0.0432981394580985,0.00330787821117374,-0.049781580751999,-0.0368146981641979,6.0741428199937e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40042,0.0379451725309387,0.00327521433677969,0.0315257524308505,0.0443645926310269,6.52912755995555e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40040,-0.0557836873046867,0.00351425232423838,-0.0626716218601939,-0.0488957527491795,2.66675777994619e-56
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40040,0.0173993075478195,0.00352812103334655,0.0104841903224602,0.0243144247731787,8.23954929403989e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40040,-0.0117457187530397,0.00354060636112968,-0.0186853072208539,-0.00480613028522555,0.00091057085166036
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40040,0.0490234896144668,0.00374047625053615,0.0416921561634159,0.0563548230655177,4.87921591220531e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40040,0.0758358412056886,0.00347474485020731,0.0690253412992823,0.082646341112095,4.83981033453299e-104
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40042,0.0335684429080912,0.00366536175214452,0.026384333873888,0.0407525519422945,5.91570263406651e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40042,-0.0635658200647938,0.00361990457495788,-0.0706608330317112,-0.0564708070978763,2.2651372514118e-68
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40042,-0.0635902579074741,0.00365634784740082,-0.0707566996883798,-0.0564238161265685,4.09514653668296e-67
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40042,-0.0310431985923568,0.00354268138635221,-0.0379868541096071,-0.0240995430751064,2.1011244589555e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40042,0.0722565796540256,0.00349717153745958,0.0654021234406048,0.0791110358674463,1.37737812185247e-93
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40042,0.0384511369750618,0.00345207389106543,0.0316850721485736,0.04521720180155,1.04496442882592e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40042,-0.0561541716062932,0.00334738210120087,-0.0627150405246469,-0.0495933026879395,1.30390493063542e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40042,-0.0552659327446203,0.00332563834536178,-0.0617841839015294,-0.0487476815877112,1.74017245233184e-61
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40042,-0.0337240185737886,0.00362039631495246,-0.0408199953510954,-0.0266280417964818,1.37911131269903e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40042,0.0622718150977819,0.003248011723086,0.0559057121205334,0.0686379180750305,5.38679805712984e-81
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40042,-0.0172892515606676,0.00321287745714733,-0.0235864913766764,-0.0109920117446588,7.50450504914025e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40042,-0.028914964843634,0.00321100433516332,-0.0352085333405541,-0.0226213963467139,2.40268164316718e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40042,-0.0254625130557616,0.00322149073219141,-0.0317766348908568,-0.0191483912206665,2.88167894816039e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40042,-0.00916102383632909,0.003281209420188,-0.0155921942998976,-0.00272985337276061,0.00524526970937773
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40042,0.0623649895901778,0.00324705067350551,0.056000770270107,0.0687292089102486,2.82326563126117e-81
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51318,-0.00479318800648029,0.00267443827032154,-0.0100350870163105,0.000448711003349928,0.0731086059782832
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51318,-0.00396622087712057,0.00261935402465763,-0.00910015476544953,0.00116771301120839,0.129987368232523
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49476,-0.00071606224187277,0.00250766355800828,-0.00563108281556901,0.00419895833182347,0.77522549914215
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49476,-0.00421590568893771,0.00272660674478745,-0.00956005490872111,0.00112824353084568,0.122066586763202
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49476,-0.00413611356090331,0.00268130186535584,-0.00939146521700075,0.00111923809519414,0.122946179906836
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49476,-0.00072853658863266,0.00245250529433238,-0.00553544696552412,0.0040783737882588,0.766424610186661
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24009.Traffic intensity on the nearest road,51318,-0.0084926820794784,0.0662625839960478,-0.138367346711732,0.121381982552775,0.898017708776434
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24010.Inverse distance to the nearest road,51318,-0.0023207771267355,0.00233722213994523,-0.00690173252102815,0.00226017826755715,0.320736507890974
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51318,0.00333036359033013,0.00234299485476022,-0.0012619063249999,0.00792263350566015,0.155208306352448
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24012.Inverse distance to the nearest major road,51318,-0.00562499941975477,0.00237726982855561,-0.0102844482837238,-0.000965550555785771,0.0179807570313927
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24013.Total traffic load on major roads,51318,0.00849447890144641,0.046037175630988,-0.0817383853352901,0.098727343138183,0.853612055867506
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51318,-0.0321177895069049,0.044651708349978,-0.119635137872862,0.0553995588590519,0.471964895333822
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51318,-0.00643625786221733,0.0026587738987319,-0.0116474547037319,-0.00122506102070281,0.0154946131758046
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51318,-0.00692341135756019,0.0026528368374032,-0.0121229715588705,-0.00172385115624991,0.00906416382042016
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51318,-0.00618438349499422,0.00262801720986985,-0.0113352972263391,-0.00103346976364932,0.0186172454680681
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51252,-0.00346571443828879,0.00258706675840234,-0.00853636528475737,0.00160493640817979,0.180376748630344
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51318,-0.00206882759598009,0.00235466424972993,-0.00668396952545075,0.00254631433349058,0.379621541824821
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24021.Average evening sound level of noise pollution,51318,-0.00204472077121368,0.00235439833181049,-0.00665934150156224,0.00256989995913488,0.38514567095282
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51318,-0.00207567167523148,0.00235460943682012,-0.00669070617139891,0.00253936282093595,0.378035965107647
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51318,-0.00205494595902804,0.00235447364672066,-0.00666971430660052,0.00255982238854445,0.382788846710364
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51318,-0.00206263352018396,0.00235441645286941,-0.00667728976780801,0.00255202272744009,0.380999836744721
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48413,0.00845771926620316,0.00273630544101326,0.00309456060181718,0.0138208779305891,0.00199761736377056
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48413,-0.00144079560940271,0.00249635588974203,-0.00633365315329708,0.00345206193449167,0.563837110792523
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24502.Water percentage, buffer 1000m",48413,-0.00255710134750397,0.0024550335887282,-0.00736896718141124,0.0022547644864033,0.297619323038958
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48413,0.00445173983985179,0.00257919525125042,-0.000603482852599039,0.00950696253230261,0.0843568976914727
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48413,0.000702275575817349,0.00251552442120741,-0.00422815228974918,0.00563270344138387,0.780111703647569
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24505.Water percentage, buffer 300m",48413,-0.00339064157017764,0.00246609967055345,-0.00822419692446241,0.00144291378410713,0.169175162878305
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51479,0.00491810760779646,0.00261165100912622,-0.000200728370090926,0.0100369435856838,0.0596919646647596
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51479,0.002674206057945,0.00246442539993944,-0.00215606772593631,0.00750447984182631,0.277876613644294
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24508.Distance (Euclidean) to coast,51479,-0.00403167813143883,0.00235345776419567,-0.00864445534926235,0.000581099086384685,0.0867079859739336
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35423,0.0918309219691686,0.0487886026541667,-0.00379473923299815,0.187456583171335,0.0598324915283977
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2704.Years since last cervical smear test,45124,0.06180458885386,0.0356393199971596,-0.0080484783405728,0.131657656048293,0.0829030849662376
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2714.Age when periods started (menarche),50829,0.0427309438807047,0.0303422984483407,-0.0167399610780431,0.102201848839452,0.159055164363487
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2734.Number of live births,51645,0.0418076649601804,0.0290559381400285,-0.0151419737942755,0.0987573037146363,0.150199386180956
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2744.Birth weight of first child,46028,-0.146194075345869,0.0321869755554315,-0.209280547434514,-0.083107603257223,5.60178874725871e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2754.Age at first live birth,42835,-0.00544453728180385,0.0029996723290211,-0.0113238950466852,0.000434820483077514,0.0695334357601319
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2764.Age at last live birth,42783,-0.00185866207905034,0.0028962958723642,-0.00753540198888418,0.0038180778307835,0.521051569423297
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2794.Age started oral contraceptive pill,45295,0.00119097473733705,0.00324159540313669,-0.00516255225281087,0.00754450172748497,0.713321506075422
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2804.Age when last used oral contraceptive pill,43355,-0.00539045483615844,0.00281187366201551,-0.0109017272137089,0.000120817541391963,0.0552487861799529
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2867.Age started smoking in former smokers,29976,0.000209001493491424,0.0054356640651809,-0.0104449000742631,0.010862903061246,0.969330254787509
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35380,-0.00485725669311249,0.0538583778837689,-0.1104196773453,0.100705163959075,0.928141283429516
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35374,0.106629610777104,0.058565426806988,-0.00815862576459225,0.221417847318801,0.0686810270868379
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35411,0.0361269686608585,0.0638773283983434,-0.0890725949998945,0.161326532321612,0.571699111861424
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35368,0.0602718273817331,0.0612808771198287,-0.0598386917731311,0.180382346536597,0.32536648277604
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28739.Difficulty with standing for long periods,35421,0.033135930910672,0.053311519817602,-0.0713546479318279,0.137626509753172,0.534248805938686
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28740.Difficulty with taking care of household responsibilities,35451,0.0431358402421082,0.0580425005578697,-0.0706274608513165,0.156899141335533,0.457390520336702
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28741.Difficulty learning a new task,35343,0.131264294177747,0.0648360502469922,0.00418563569364283,0.258342952661852,0.0429372114678023
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28742.Difficulty with joining in community activities,35060,0.0314111300233312,0.0687689948780068,-0.103376099937562,0.166198359984224,0.647850782813617
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35374,0.0660850091457676,0.0571498835225753,-0.04592876255848,0.178098780850015,0.247565173927365
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35444,0.0144669533655232,0.0843990161710437,-0.150955118329722,0.179889025060769,0.863903449095395
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29946,0.094456898512389,0.0669357258185402,-0.0367371240919499,0.225650921116728,0.158254605582753
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2897.Age stopped smoking,29986,0.0118728055937369,0.00556770091987182,0.00096011179078812,0.0227854993966857,0.0330143233024664
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34313,-0.00226061638384959,0.00774536130628916,-0.0174415245441763,0.0129202917764772,0.770394355040499
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34313,0.00939702259775019,0.00825064995046404,-0.00677425130515934,0.0255682965006597,0.254754465324433
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34313,-0.0111172672874825,0.0276428902520994,-0.0652973321815974,0.0430627976066324,0.687564278472053
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34313,0.00884931624758061,0.0288819467917707,-0.0477592994642899,0.0654579319594511,0.759309535878751
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34313,0.0492759766651132,0.0303520845251206,-0.0102141090041232,0.10876606233435,0.104518978532295
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34313,0.0157128388495357,0.0250900854137462,-0.0334637285614069,0.0648894062604784,0.531160953795939
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34313,-0.0125325304378032,0.0116306024933139,-0.0353285113246985,0.0102634504490921,0.281261955342688
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34313,0.00698801462971079,0.0206796543886056,-0.0335441079719561,0.0475201372313777,0.735432643140023
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34238,0.0582688788472275,0.0645607782015799,-0.068270246427869,0.184808004122324,0.366790705146079
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29003.Recent feelings of depression,34221,0.0393615206133683,0.0617561068852018,-0.0816804488816272,0.160403490108364,0.523898480203794
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34241,0.0831194368681594,0.0507093594191792,-0.0162709075934319,0.182509781329751,0.101217489637651
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29005.Recent feelings of tiredness or low energy,34248,0.1145316131372,0.0515681425174496,0.0134580538029989,0.215605172471401,0.0263753632796343
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29006.Recent poor appetite or overeating,34257,0.0688971881376152,0.0663437159279873,-0.0611364950812398,0.19893087135647,0.299068285222495
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29007.Recent feelings of inadequacy,34211,0.0222307640585653,0.0669153563537845,-0.108923334394852,0.153384862511983,0.739728650306174
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29008.Recent trouble concentrating on things,34257,-0.0505642960560663,0.0673647290432051,-0.182599164980748,0.0814705728686157,0.452908484014013
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34244,0.161273387381073,0.119736375291716,-0.0734099081906893,0.395956682952836,0.178042371508162
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29010.Recent thoughts of suicide or self-harm,34179,0.166310208830733,0.135045301832634,-0.0983785827612301,0.430999000422696,0.218160382224117
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#0.Substances taken for depression_None of options listed,32973,-0.027162263515076,0.0151741998551181,-0.0569036952311075,0.00257916820095547,0.0734846827046109
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32973,-0.0231395317760989,0.0302182011398137,-0.0823672060101339,0.036088142457936,0.443847377987842
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32973,-0.0343912379251438,0.01421157260269,-0.0622459202264163,-0.00653655562387137,0.0155435972642942
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32973,-0.0303852840104035,0.0403722815160632,-0.109514955781887,0.0487443877610803,0.451694657301495
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32973,-0.0604766104724568,0.025857384840351,-0.111157084759545,-0.00979613618536888,0.0193660564715493
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32973,-0.0432122182893303,0.0270727169391113,-0.0962747434899884,0.00985030691132784,0.110491557001821
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32973,-0.0232305489372684,0.0311140760010472,-0.0842141378993209,0.0377530400247841,0.455310514681066
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32973,-0.0463025081592114,0.0365295307563154,-0.11790038844159,0.0252953721231669,0.204998210814168
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32973,-0.0456223491376199,0.0275241121070548,-0.0995696088674473,0.0083249105922075,0.0974469229752785
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32973,-0.0188573849107376,0.0152804794777695,-0.0488071246871659,0.0110923548656907,0.21720589157414
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32973,0.00249865274529055,0.0229048532987644,-0.0423948597202877,0.0473921652108688,0.913134980621666
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32973,-0.0601956172770096,0.0356301803213879,-0.13003077070693,0.00963953615291071,0.0911686851305276
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32973,-0.0356992707772628,0.0470949497345541,-0.128005372256989,0.0566068307024633,0.448455435476997
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32973,-0.00480613721499093,0.0306226888720404,-0.06482660740419,0.0552143329742082,0.87529038638031
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32973,-0.108595210867413,0.0519801709167921,-0.210476345864325,-0.00671407587050014,0.0367223659261993
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32973,-0.141748264550166,0.049317186116881,-0.238409949339252,-0.0450865797610788,0.00406033572443065
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32973,-0.0668566888810901,0.0262635837314857,-0.118333312994802,-0.0153800647673781,0.0109263420947434
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32973,-0.0124469106934246,0.026111084343367,-0.0636246360064238,0.0387308146195747,0.633594620306079
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32973,-0.0533468634090778,0.03563044604137,-0.123182537650163,0.0164888108320074,0.134371259089838
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29058.Recent feelings or nervousness or anxiety,34102,0.0456414864290901,0.0573639864843743,-0.0667919270802836,0.158074899938464,0.42625678763225
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29059.Recent inability to stop or control worrying,34114,0.0784637011639697,0.0590477153109976,-0.0372698208455856,0.194197223173525,0.183939217453886
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29060.Recent worrying too much about different things,34107,0.0714413719802216,0.0553418741654468,-0.0370287013840542,0.179911445344497,0.19676584511193
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29061.Recent trouble relaxing,34111,0.0215277847883021,0.0585178968295264,-0.0931672929975697,0.136222862574174,0.712967961539543
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29062.Recent restlessness,34122,0.0794053621695849,0.0850865681202577,-0.0873643113461201,0.24617503568529,0.3507243870517
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29063.Recent easy annoyance or irritability,34089,0.0477562040403594,0.0612905316139314,-0.0723732379229461,0.167885646003665,0.435894290909049
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29064.Recent feelings of foreboding,34078,0.125158425812715,0.0665514687882046,-0.00528245301216571,0.255599304637596,0.0600529764080096
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32973,-0.0375382594788252,0.0148019170580065,-0.0665500169125179,-0.00852650204513255,0.0112290885246781
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32973,-0.012925751190593,0.0260510343149631,-0.0639857784479207,0.0381342760667348,0.619787015827769
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32973,0.00875824615646696,0.032276729756686,-0.0545041441666375,0.0720206364795714,0.786129486590195
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32973,-0.101335646668082,0.0357613514302694,-0.17142789547141,-0.0312433978647536,0.00461258723481556
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32973,-0.0125953741996955,0.0244791831171886,-0.0605745731093851,0.0353838247099941,0.606891977688625
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32973,-0.0166995658595885,0.0240343846303461,-0.0638069597350668,0.0304078280158898,0.487187195137113
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32973,-0.057715142579623,0.0246891800358666,-0.106105935449922,-0.00932434970932444,0.0194274235775718
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32973,-0.0522829580123779,0.0221608630052135,-0.0957182495025963,-0.00884766652215955,0.0183344776791525
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32973,-0.0589664172587973,0.0303906772250394,-0.118532144619875,0.000599310102279982,0.0523786412856299
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29076.Felt loved as a child,34079,-0.0165348901695226,0.0541234231941226,-0.122616799630003,0.0895470192909577,0.759989382960443
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29077.Physically abused by family as a child,34093,0.0751764158552328,0.0755467020731317,-0.0728951202081054,0.223247951918571,0.319713303780633
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29078.Felt hated by family member as a child,34073,0.00556455084795307,0.0704608117459629,-0.132538640174134,0.14366774187004,0.937055186810055
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29079.Sexually molested as a child,33966,0.00302863119206583,0.0894605355724768,-0.172314018529989,0.17837128091412,0.972993980203486
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29080.Someone to take to doctor when needed as a child,34047,-0.164422826406322,0.0758518061456564,-0.313092366451808,-0.0157532863608352,0.0302071737416831
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34076,-0.119806124367473,0.0929648675059127,-0.302017264679062,0.0624050159441159,0.197524780355136
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,33996,-0.0301409512412219,0.0706541294343957,-0.168623044932638,0.108341142450194,0.669681355489483
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34074,0.0944501917428277,0.079291733281042,-0.0609616054880146,0.24986198897367,0.233614963336865
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34035,-0.0192924666034856,0.0972394225013557,-0.209881734706143,0.171296801499172,0.84273499754453
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34040,-0.0265155853027099,0.0972818897443992,-0.217188089201732,0.164156918596313,0.785193908284777
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29086.Experienced a violent or sexual assault,34070,-0.0982499277957454,0.0915756108251894,-0.277738125013117,0.0812382694216258,0.283350477516219
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29087.Experienced a life-threatening injury or illness,34081,0.0294395106688,0.0652498432611692,-0.0984501821230917,0.157329203460692,0.651869030301835
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29088.Experienced a marital separation or divorce,34088,-0.102671039420081,0.0578176442408112,-0.215993622132071,0.0106515432919091,0.0758018155896972
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29089.Experienced the death of a spouse or partner,34096,-0.0652468411383115,0.0732110205313539,-0.208740441379765,0.078246759103142,0.372835477737453
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34080,0.026665943958682,0.0733910565551873,-0.117180526889485,0.170512414806849,0.716358512834426
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34095,-0.138431691519507,0.0482371401972678,-0.232976486306152,-0.0438868967328623,0.00411604658839225
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,32861,-0.129628507803673,0.05938151718181,-0.246016281480021,-0.0132407341273255,0.029065046591548
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,32875,-0.066576480133581,0.0611270613072683,-0.186385520295827,0.0532325600286647,0.276119338155064
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29104.Ever used cannabis,34088,-0.0463850909658517,0.0748290015630933,-0.193049934029515,0.100279752097811,0.535350668787599
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29108.Ever thought that life not worth living,34034,-0.0314155224702895,0.0588081573274582,-0.146679510832107,0.0838484658915286,0.593213154206214
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29109.Ever contemplated self-harm,34070,-0.0495101277211027,0.0774447002237153,-0.201301740159585,0.102281484717379,0.522645275447097
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29111.Ever self-harmed,34085,-0.0376287383829128,0.120787022973404,-0.274371303410785,0.19911382664496,0.755404752223402
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34079,-0.0783548215570981,0.0810522932427713,-0.23721731631293,0.0805076731987338,0.333708629805043
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33664,-0.0545195524841148,0.0326640091295963,-0.118541010378124,0.00950190540989387,0.0951312106691316
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33664,-0.04401561105186,0.0250507989806571,-0.0931151770539478,0.00508395495022788,0.0789417915136704
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33664,-0.0540823599703856,0.025239717580186,-0.10355220642755,-0.004612513513221,0.0321594457974952
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33664,-0.0581800746646586,0.0328397285219249,-0.122545942567631,0.00618579323831418,0.0764879038657495
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34073,-0.102948766511814,0.0541231614177858,-0.209030162890675,0.00313262986704566,0.0571852606609605
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X29153.Pain or discomfort today,34086,0.00517388195012442,0.0516623308479715,-0.0960842865118998,0.106432050412149,0.920228869213282
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29154.Anxiety or depression today,34086,-0.00328124452287282,0.062043988615523,-0.124887462209298,0.118324973163552,0.957824013996055
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29166.Frequency of confiding in someone close,33848,0.010289557229554,0.0506085907437836,-0.0889032806282618,0.10948239508737,0.83889213086256
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34052,0.0130746686808294,0.00830305439430784,-0.00319931793201394,0.0293486552936728,0.115362861840074
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34052,-0.0215021632987304,0.00813355631236066,-0.0374439336709573,-0.0055603929265035,0.00821540815954145
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34052,-0.0101020442381882,0.0118868912443556,-0.0334003510771252,0.0131962626007488,0.395431097150751
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34052,0.0118784662454053,0.0103983887928994,-0.00850237578867742,0.0322593082794881,0.253342377443692
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34052,-0.0142223474765932,0.0154691738431067,-0.0445419282090823,0.0160972332558959,0.357909859742632
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34052,-0.00703954279673054,0.00814962292865492,-0.0230128037368942,0.00893371814343311,0.387726190656082
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34052,0.00912466958796904,0.00906686157518424,-0.00864637909939208,0.0268957182753302,0.314260220650317
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34052,-0.0324330667829154,0.0126981762568152,-0.0573214922462731,-0.00754464131955765,0.010659995078105
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34052,-0.0230261405332762,0.0261935431894354,-0.0743654851845695,0.0283132041180171,0.37938154729599
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34052,0.0280807863282278,0.0174128004786333,-0.00604830260989351,0.0622098752663491,0.106853019291262
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34052,-0.0256122162049276,0.0243430798227621,-0.0733246526575413,0.0221002202476862,0.292763911368037
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34052,0.0044234830859656,0.012939788684647,-0.0209385027359426,0.0297854689078738,0.732470312634086
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29171.Frequency of feeling 'in tune' with people,33943,0.0496355879124316,0.063093620385502,-0.0740279080431524,0.173299083868016,0.43147866347964
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29172.Freuency of feeling that lacks companionship,34026,-0.0831620782959429,0.0563978189344738,-0.193701803407512,0.0273776468156258,0.140363233115434
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29173.Frequency of feeling left out,33967,0.0177629591009047,0.0586288522632636,-0.0971495913350919,0.132675509536901,0.761917064061241
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29174.Frequency of feeling isolated from others,33998,-0.0739319855315936,0.0610661788390322,-0.193621696056097,0.0457577249929096,0.22604563565502
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34071,-0.0394911332241901,0.0508118936025798,-0.139082444685246,0.0601001782368664,0.4370583974106
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29176.Ability to make it through stressful events,34071,0.072178144229235,0.0496030093337834,-0.0250437540649806,0.169400042523451,0.145669727437887
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29177.Quick recovery from stressful events,34071,-0.00272817804869905,0.0503852927834132,-0.101483351904189,0.0960269958067909,0.956819715325709
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29178.Hard to snap back when something bad happens,34071,0.0122614036290534,0.0498775811968353,-0.0854986555167439,0.110021462774851,0.805819112925546
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29179.Comes through difficult times with little trouble,34071,0.0235342004885418,0.0501736078528302,-0.0748060709030055,0.121874471880089,0.639040688540242
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34071,0.0597566089514565,0.0503805056061341,-0.0389891820365664,0.158502399939479,0.235609833538337
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29181.General happiness,34015,-0.0294776077345663,0.0521529158377998,-0.131697322776654,0.0727421073075213,0.571940833839994
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29182.Belief that own life is meaningful,33917,-0.0283937117989588,0.0515593818289368,-0.129450100183675,0.0726626765857573,0.581852874762648
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29538,0.0188008643815905,0.0683801134408974,-0.115224157962568,0.152825886725749,0.783368606896131
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2946.Father's age,30619,0.000375240472943167,0.00740434921230579,-0.0141372839831762,0.0148877649290625,0.959583440652744
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2966.Age high blood pressure diagnosed,30248,0.00109711420926743,0.00585583342735338,-0.0103803193083452,0.01257454772688,0.851389591855373
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50753,0.0273953153131578,0.0024775740744598,0.0225392701272165,0.032251360499099,2.33343869238245e-28
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50753,0.0422360394291643,0.00289730824027281,0.0365573152782296,0.047914763580099,5.99373482777608e-48
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30020.Haemoglobin concentration,50753,0.0336593952983738,0.00315498463889425,0.0274756254061411,0.0398431651906066,1.61689815288852e-26
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30030.Haematocrit percentage,50753,0.0339474122978467,0.00305951566847942,0.0279507615876271,0.0399440630080664,1.52340141435973e-28
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30040.Mean corpuscular volume,50753,-0.0168264777787221,0.00243402105202343,-0.021597159040688,-0.0120557965167561,4.85220575917955e-12
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50752,-0.0164355348262493,0.00244012030441981,-0.0212181706229121,-0.0116528990295864,1.66684297095348e-11
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50752,-0.00464739289742197,0.0023903272406069,-0.0093324342890115,3.76484941675623e-05,0.051876001593356
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50753,0.00570382368952177,0.00230864138998247,0.00117888656515614,0.0102287608138874,0.0134934119712731
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30080.Platelet count,50753,0.0364437814528794,0.00243688762886673,0.0316674817003006,0.0412200812054582,2.32614512524665e-50
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30090.Platelet crit,50753,0.0345222098703758,0.00249931017815444,0.0296235619211931,0.0394208578195585,3.02610023103807e-43
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50753,-0.0142607101771625,0.00236615205863095,-0.0188983682120792,-0.00962305214224588,1.69291623613552e-09
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30110.Platelet distribution width,50753,0.00617801213326416,0.00236351777105985,0.00154551730198686,0.0108105069645415,0.008956477849517
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30120.Lymphocyte count,50714,0.0110090473953772,0.00246855540386166,0.00617067880380834,0.015847415986946,8.24097712112326e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30130.Monocyte count,50714,0.0156696551691572,0.00250118453116716,0.0107673334880695,0.0205719768502448,3.78865477994345e-10
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30140.Neutrophill count,50714,0.0247425642041757,0.00245942479231343,0.0199220916112414,0.0295630367971101,9.136807793309e-24
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30150.Eosinophill count,50714,0.0188099024513145,0.00242322514963496,0.0140603811580299,0.023559423744599,8.64007311824071e-15
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30160.Basophill count,50714,0.0845579922294729,0.0328862985237529,0.0201008471229172,0.149015137336029,0.0101394708005819
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30170.Nucleated red blood cell count,50714,0.470110864709385,0.142722773217417,0.190374229203248,0.749847500215521,0.000989473768088206
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30180.Lymphocyte percentage,50714,-0.0121177066360684,0.00243611004744777,-0.016892482329066,-0.00734293094307077,6.59297808353256e-07
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30190.Monocyte percentage,50714,-0.00391357292987829,0.00246823265609952,-0.00875130893583334,0.000924163076076767,0.112847337090665
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30200.Neutrophill percentage,50714,0.00879487854157577,0.00241454152769986,0.00406237714728404,0.0135273799358675,0.000270561116304551
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30210.Eosinophill percentage,50714,0.00913688154613862,0.00239827585866314,0.00443626086315886,0.0138375022291184,0.000139412420781604
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30220.Basophill percentage,50714,-0.00213711970285495,0.00229814503753655,-0.00664148397642658,0.00236724457071668,0.352414594933817
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,50714,0.468335706144701,0.142630891710434,0.18877915839225,0.747892253897153,0.00102642342870662
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30240.Reticulocyte percentage,50281,0.0313023669871908,0.00251014958306869,0.0263824738043762,0.0362222601700054,1.37258768907215e-35
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30250.Reticulocyte count,50281,0.0393261794475778,0.00258993168736604,0.0342499133403404,0.0444024455548153,7.5324656257985e-52
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30260.Mean reticulocyte volume,50281,-0.00906019502192447,0.00241088993540132,-0.013785539295311,-0.00433485074853789,0.00017163350274009
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30270.Mean sphered cell volume,50281,-0.0187728039075988,0.00243515685235187,-0.0235457113382084,-0.0139998964769891,1.31284266489237e-14
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50281,0.0140933731691643,0.00254372411321471,0.00910767390726348,0.0190790724310652,3.04637977883553e-08
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50281,0.0308390363030443,0.00258045540547325,0.0257813437083167,0.0358967288977718,7.83048278551216e-33
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50281,0.0377129627646146,0.00264299824226136,0.0325326862097823,0.0428932393194468,5.1087300664331e-46
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30500.Microalbumin in urine,32038,0.0111867734314473,0.00473054594317215,0.00191490338282988,0.0204586434800647,0.018065062036128
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50800,0.00961796449545235,0.00251893917871122,0.00468084370517836,0.0145550852857263,0.000134703947349076
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30520.Potassium in urine,50746,0.00283807916626478,0.00234674633489515,-0.00176154365012971,0.00743770198265927,0.226532494035976
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30530.Sodium in urine,50720,0.0156345957574195,0.00246782155290313,0.0107976655137293,0.0204715260011096,2.40587604143011e-10
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30600.Albumin,48047,0.00670419051351317,0.00260179319834527,0.00160467584475644,0.0118037051822699,0.0099792032359563
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30610.Alkaline phosphatase,50379,0.0282857046095201,0.0024589329452546,0.0234661960368211,0.0331052131822191,1.50713136590987e-30
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30620.Alanine aminotransferase,50388,0.0465327871644448,0.00255519530015868,0.0415246043761338,0.0515409699527558,1.2144712271328e-73
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30630.Apolipoprotein A,47835,-0.0191571387916369,0.00285633720928552,-0.0247555597218366,-0.0135587178614373,2.0335211135111e-11
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30640.Apolipoprotein B,50285,0.0417081747867087,0.00243329733662311,0.0369389120069274,0.04647743756649,1.70243153316064e-65
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30650.Aspartate aminotransferase,50309,0.0303533709929481,0.00247943639601906,0.0254936756567508,0.0352130663291455,2.30720409341828e-34
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30660.Direct bilirubin,44625,-0.00188956268415157,0.0028121901580079,-0.00740145539384705,0.00362233002554391,0.501643256273355
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30670.Urea,50373,-0.00392594743050322,0.00255983563653644,-0.00894322527811463,0.00109133041710819,0.125122647797756
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30680.Calcium,48053,0.024404801087626,0.00248688517462206,0.0195305061453668,0.0292790960298852,1.08957335294666e-22
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30690.Cholesterol,50387,0.030081180824371,0.00251621318186673,0.0251494029879122,0.0350129586608298,7.46406632426005e-33
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30700.Creatinine,50380,-0.0023060409597426,0.00279649653526031,-0.00778717416885281,0.00317509224936761,0.409596170176646
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30710.C-reactive protein,50324,0.0506713227831861,0.00268116275361377,0.0454162437861031,0.0559264017802691,3.96928393161544e-79
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30720.Cystatin C,50385,0.0492433298106063,0.00273182015858993,0.04388896229977,0.0545976973214426,3.37293350847851e-72
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50383,0.0522639787862256,0.00249930180943981,0.0473653472397236,0.0571626103327276,2.63072863107712e-96
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30740.Glucose,48027,0.00465504419458175,0.00269489118239215,-0.000626942522906861,0.00993703091207036,0.0841163295228811
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50209,0.0218420523153663,0.00272911070676746,0.0164929953301021,0.0271911093006305,1.26136287397717e-15
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30760.HDL cholesterol,48039,-0.0420738633375457,0.00299503528240666,-0.0479441324910628,-0.0362035941840287,1.20178036128264e-44
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30770.IGF-1,50245,-0.0189055534487063,0.00246520887138343,-0.0237373628366178,-0.0140737440607948,1.79521709394636e-14
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30780.LDL direct,50334,0.0364372502863758,0.00245015576117265,0.0316349449944774,0.0412395555782742,8.11953738734819e-50
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30790.Lipoprotein A,45221,-0.00537671860767341,0.00269190566538303,-0.0106528537118242,-0.000100583503522662,0.0457985511331852
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30810.Phosphate,48007,0.00734457319727663,0.00268275609093363,0.00208637125904671,0.0126027751355065,0.00619174999789243
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30830.SHBG,47784,-0.0241075237329261,0.00282231461689829,-0.0296392603820468,-0.0185757870838055,1.40157314430687e-17
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30840.Total bilirubin,50291,-0.00115676965256516,0.00247684529659706,-0.00601138643389539,0.00369784712876507,0.640479870240081
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30850.Testosterone,45962,-0.00191503645786378,0.00439720004346898,-0.010533548543063,0.00670347562733542,0.663194693534913
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30860.Total protein,48044,0.0207795088802138,0.0025380771478375,0.0158048776704523,0.0257541400899753,2.80998563702615e-16
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30870.Triglycerides,50377,0.0659907071228308,0.00270331253428635,0.0606922145556295,0.071289199690032,3.84905980000346e-130
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30880.Urate,50351,0.0416696019841066,0.00299781810869484,0.0357938784910648,0.0475453254771485,9.10245303663818e-44
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30890.Vitamin D,48871,-0.0171861692735918,0.00268270045864993,-0.0224442621725456,-0.0119280763746379,1.51815366556357e-10
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3137.Number of measurements made,49279,0.0469369230932652,0.0369789327206598,-0.025541785039228,0.119415631225758,0.204350190919455
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3143.Ankle spacing width,39882,0.00128307245143602,0.00419199432473318,-0.00693323642504101,0.00949938132791305,0.759550257005013
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39881,-0.00870370557278752,0.00339995938759914,-0.0153676259724818,-0.0020397851730932,0.0104783433074075
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3146.Speed of sound through heel,39882,-0.00598059224770715,0.00328101598714121,-0.0124113835825039,0.000450199087089619,0.068355047891528
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39882,-0.00719422526587824,0.00332195029398312,-0.0137052478420852,-0.000683202689671319,0.0303522075266788
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3148.Heel bone mineral density (BMD),39880,-0.00730779813884859,0.00331355290979884,-0.0138023618420543,-0.000813234435642869,0.0274388570054868
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X3526.Mother's age at death,40598,0.0016544322929794,0.00316400017340574,-0.00454700804689586,0.00785587263285465,0.601056166023639
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X3581.Age at menopause (last menstrual period),39978,-0.00194183675017514,0.00317387916796425,-0.00816263991938507,0.00427896641903478,0.540667065835935
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30081,0.00633064755979489,0.00523261764979513,-0.00392528303380356,0.0165865781533933,0.226389821129843
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4100.Ankle spacing width (left),33198,-0.0114024089450696,0.00562249226528755,-0.0224224937850332,-0.000382324105106035,0.0425905967320235
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33196,-0.0071220182731994,0.00459626945062288,-0.0161307063964202,0.00188666985002145,0.121292600793874
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4103.Speed of sound through heel (left),33198,-0.00866166207552005,0.00447555887529744,-0.017433757471103,0.000110433320062929,0.0529825922205603
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33198,-0.00871837428339743,0.00451383959157936,-0.017565499882893,0.000128751316098108,0.0534564452420079
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),33196,-0.00840128460324964,0.00450087659263049,-0.0172230027248054,0.00042043351830612,0.0619925164432374
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33198,-0.00871529082904053,0.00451358986852538,-0.0175619269713503,0.000131345313269219,0.0535276974049953
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4119.Ankle spacing width (right),33199,-0.00737256895773885,0.00553328557176047,-0.0182178086783894,0.00347267076291166,0.182762348654508
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33199,-0.00572645994244453,0.00458770302431933,-0.0147183578701104,0.00326543798522135,0.211984129609144
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4122.Speed of sound through heel (right),33199,-0.00624979667952093,0.00448815610619391,-0.015046582647661,0.00254698928861914,0.163803787652929
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33199,-0.00630738193194515,0.00451858178562443,-0.015163802231769,0.00254903836787874,0.162787129569924
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),33196,-0.00565859089431033,0.00450856634907508,-0.0144953809384975,0.00317819914987682,0.209484917016952
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33199,-0.00631304732732833,0.004518581219271,-0.0151694665170995,0.00254337186244284,0.162409792128318
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4194.Pulse rate,33459,0.027580687675004,0.00436254019915765,0.019030108884655,0.036131266465353,2.70178684389251e-10
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4195.Pulse wave reflection index,33459,0.00165279493782325,0.004381232572414,-0.00693442090410819,0.0102400107797547,0.706000962408772
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4196.Pulse wave peak to peak time,33456,-0.0202914657751183,0.00400077190829597,-0.0281329787153784,-0.0124499528348582,4.01742889329271e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4198.Position of the pulse wave peak,33459,0.0159214945275918,0.0038692858815719,0.00833769419971092,0.0235052948554728,3.90898214876668e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4199.Position of pulse wave notch,33459,0.0106454063352689,0.00431207079776188,0.00219374757165564,0.0190970650988822,0.0135771761475809
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33459,0.0188159031248615,0.00386412918971332,0.0112422099130234,0.0263895963366996,1.13855204216317e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4269.Number of triplets attempted (left),33364,0.0806368209681273,0.160061330514039,-0.233083386839389,0.394357028775644,0.614423521042998
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4270.Volume level set by participant (left),33273,0.0488517510587159,0.050642491686016,-0.0504075326458755,0.148111034763307,0.334751829199688
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4276.Number of triplets attempted (right),33361,0.0610948698571038,0.155134198416186,-0.242968159038621,0.365157898752829,0.693723757656174
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4277.Volume level set by participant (right),33254,0.0505092597233907,0.0502865838331124,-0.0480524445895095,0.149070964036291,0.315199913907228
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4288.Time to answer,33535,-0.0039213418783527,0.0048728761145208,-0.0134721790628135,0.00562949530610807,0.420997480659292
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4290.Duration screen displayed,33535,0.00192325113512691,0.00434204112721192,-0.00658714947420844,0.0104336517444623,0.657821774928823
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X46.Hand grip strength (left),51564,-0.0168814961987837,0.00356675041972504,-0.0238723270214448,-0.0098906653761226,2.22320858056919e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X47.Hand grip strength (right),51565,-0.0167434009159189,0.00355127488127995,-0.0237038996832276,-0.00978290214861023,2.43200933575388e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X48.Waist circumference,51651,0.0558033208695757,0.00474354595130693,0.0465059708050141,0.0651006709341373,7.14419488078866e-32
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X4803.Tinnitus,33375,-0.0388136628044867,0.0617339019715616,-0.159812110668747,0.082184785059774,0.529545044976981
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4825.Noisy workplace,33507,0.179881946116673,0.0875267694842177,0.00832947792760638,0.35143441430574,0.0398917053244524
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4836.Loud music exposure frequency,33454,0.033847212384343,0.101159323243393,-0.164425061172708,0.232119485941394,0.73793984137617
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X49.Hip circumference,51648,-0.0377146878291652,0.00402901077257658,-0.0456115489434153,-0.0298178267149151,8.50607715057164e-21
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X50.Standing height,51645,-0.0165584078758873,0.00330258218189378,-0.0230314689523991,-0.0100853467993755,5.37072796223838e-07
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X5057.Number of older siblings,32456,0.00402533402066392,0.0541638549303621,-0.102135821642846,0.110186489684174,0.940759437605926
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X51.Seated height,51522,-0.0114438906773224,0.00331247244626331,-0.0179363366719985,-0.00495144468264631,0.000551568694871815
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5181.Ever had eye surgery,30580,-0.076644209392667,0.121634005049468,-0.315046859289625,0.161758440504291,0.528638554873162
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30562,0.000159697308881507,0.00501784621747694,-0.0096752812773733,0.00999467589513632,0.974611957308719
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30564,-0.0030160836246921,0.00496650885198695,-0.0127504409745865,0.00671827372520231,0.543684712006946
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5190.Duration at which refractometer first shown (right),30491,-0.00605693637014965,0.00501305063102807,-0.0158825156069647,0.00376864286666537,0.227004718823391
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5193.Duration at which refractometer first shown (left),30492,-0.00623867818491907,0.0050436750369594,-0.0161242812573595,0.00364692488752136,0.21616077696454
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5199.logMAR, initial (right)",30544,0.00396438909646861,0.0647815935048292,-0.123007534172997,0.130936312365934,0.951204942368953
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5200.Final number of letters displayed (right),30544,-0.361424149600394,0.450577869423791,-1.24455677367102,0.521708474470235,0.422506336168419
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5201.logMAR, final (right)",30495,0.0082183051776048,0.00522673414101292,-0.00202609373878052,0.0184627040939901,0.115919548677484
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5202.Number of rounds to result (right),30544,-0.0537273045389681,0.060409708974545,-0.172130334129076,0.0646757250511401,0.373833025362565
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5206.logMAR, initial (left)",30542,0.0618240899170172,0.0637586075564862,-0.0631427808936957,0.18679096072773,0.332255146297743
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5207.Final number of letters displayed (left),30542,-0.150700774046888,0.385969962026852,-0.907201899619518,0.605800351525743,0.696219776043927
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5208.logMAR, final (left)",30479,0.00460755729756874,0.0051833936913055,-0.00555189433739004,0.0147670089325275,0.374088293814235
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5209.Number of rounds to result (left),30540,0.0583749869832575,0.0601801378063086,-0.0595780831171074,0.176328057083622,0.33208299838366
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30251,0.00210822352904984,0.00516062811063644,-0.00800660756779758,0.0122230546258973,0.682906503469116
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30251,0.00879922068181313,0.00521733659390292,-0.00142675904223659,0.0190252004058628,0.0917465919521243
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5256.Corneal hysteresis (right),30251,0.0108388082077806,0.00515681027325408,0.000731460072202577,0.0209461563433586,0.0356100092491725
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5257.Corneal resistance factor (right),30251,0.0125150603133367,0.00517646331420409,0.00236919221749667,0.0226609284091767,0.0156502034330757
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30254,0.0116329905574589,0.0050986173436801,0.00163970056384592,0.0216262805510719,0.0225491986043886
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30254,0.0130896684996495,0.00508461274935751,0.00312382751090875,0.0230555094883902,0.0100668885540774
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5264.Corneal hysteresis (left),30254,0.00175995728303374,0.00520663724784479,-0.00844505172274205,0.0119649662888095,0.735358933036402
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5265.Corneal resistance factor (left),30254,0.00863977715722867,0.00515977733342552,-0.00147338641628536,0.0187529407307427,0.0940965453008215
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29846,0.592116220312584,0.288053168042222,0.02753201094983,1.15670042967534,0.0398710960141202
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51562,0.000679080390330393,0.0138657278724855,-0.0264977462397412,0.027855907020402,0.960939213932889
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51562,-0.0228095156862913,0.0143362029059888,-0.0509084733820294,0.00528944200944679,0.111611552307854
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51562,0.0337636117699333,0.0366726684085205,-0.0381148183107667,0.105642041850633,0.357228284958238
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51562,-0.019932446092542,0.00604645118116105,-0.0317834904076177,-0.00808140177746634,0.000980049416569674
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51562,0.0101177141575582,0.0055259927692531,-0.000713231670177892,0.0209486599852942,0.067121739749728
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37009,0.000761757754805435,0.00686927118258646,-0.012702013763064,0.0142255292726749,0.91170254568855
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37009,0.00174697392346952,0.017234981879555,-0.0320335905604583,0.0355275384073974,0.91926464118283
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37009,-0.0188074321464929,0.0134330562041926,-0.0451362223067104,0.00752135801372463,0.161512312861575
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37009,0.0104422371667599,0.00826970368402252,-0.00576638205392427,0.026650856387444,0.206716882994758
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51645,0.0283688212791772,0.0113876949951377,0.00604893908870741,0.050688703469647,0.0127378016038794
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51645,0.0283688212791772,0.0113876949951377,0.00604893908870741,0.050688703469647,0.0127378016038794
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51645,0.00048845839609656,0.00909665848090768,-0.0173409922264825,0.0183179090186756,0.957177394380136
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51645,0.0189690011436853,0.0142951441090116,-0.00904948130997755,0.046987483597348,0.184534983966153
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51645,0.0619878248131615,0.035625923247453,-0.0078389847518465,0.131814634378169,0.081876648333625
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51645,0.0345158807667827,0.0241052481215201,-0.0127304055513966,0.081762167084962,0.152188970705158
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51645,-0.0066002385933688,0.0387519031310038,-0.0825539687301362,0.0693534915433986,0.864759457142451
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51562,-0.00335443055030396,0.007314229744007,-0.0176903208485577,0.0109814597479498,0.64651285904599
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51562,0.00187329964004166,0.0122228572569693,-0.0220835005836182,0.0258300998637015,0.878192800997458
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51562,0.00357786873811288,0.00648957736952245,-0.00914170290615112,0.0162974403823769,0.581415183966992
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51562,0.0272880117228963,0.0120141444325208,0.00374028863515555,0.0508357348106371,0.0231351897240182
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51562,0.0145161441096199,0.0116635286278129,-0.00834437200089335,0.0373766602201331,0.213298522607307
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51562,0.029571481299245,0.00657077926795367,0.0166927539340558,0.0424502086644342,6.80907454057172e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31722,-0.0697273462626774,0.0247151566523148,-0.118169053301214,-0.0212856392241405,0.00479683685315655
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31722,-0.0571702033611733,0.0160908470649754,-0.0887082636085251,-0.0256321431138216,0.000383331463544829
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31722,-0.0100072428159837,0.0205695692846559,-0.0503235986139093,0.030309112981942,0.62662229256704
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31722,0.030260699543345,0.0183186706198306,-0.00564389487152294,0.066165293958213,0.0985971498153011
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51556,0.00315204307419065,0.0179079610610151,-0.0319475606053989,0.0382516467537802,0.860284644067471
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51556,0.0320824487644793,0.0303422776245339,-0.0273884153796072,0.0915533129085659,0.290360681157846
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51556,0.0396434471242119,0.0484980607850972,-0.0554127520145787,0.134699646263002,0.413693723733075
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51556,0.0391150091452978,0.0473481964139787,-0.0536874558261005,0.131917474116696,0.408746683817541
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51556,0.0123081017744264,0.0148545561100188,-0.0168068282012104,0.0414230317500633,0.407352694758195
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51556,0.00381693437376243,0.0213650987143705,-0.0380586591064038,0.0456925278539287,0.858211680490934
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51556,0.00185954767236133,0.0105502731696415,-0.018818987740136,0.0225380830848587,0.860094239511605
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33791,-0.00453747994732577,0.01572221928766,-0.0353530297511393,0.0262780698564877,0.772891590368736
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33791,0.0563233834877301,0.0181793093978836,0.0206919370678782,0.091954829907582,0.00195269056443378
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33791,-0.0433715603083997,0.0239324213641454,-0.0902791061821247,0.00353598556532538,0.0699794853561993
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33791,0.00590587511091802,0.00823042446399591,-0.010225756838514,0.02203750706035,0.473042699479015
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37278,-0.0131140723365184,0.00838936594004273,-0.0295572295790021,0.00332908490596538,0.118035402615673
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37278,-0.00691413570297817,0.00731470485667173,-0.0212509572220548,0.00742268581609843,0.344555279037337
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37278,-0.00831038124830266,0.00686796141109149,-0.021771585614042,0.00515082311743666,0.226292927323957
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37278,-0.00946964805940298,0.0165114283819239,-0.0418320476879739,0.0228927515691679,0.566302157184493
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37278,0.040359065867721,0.00988211946104158,0.0209901117240795,0.0597280200113625,4.45263616356641e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37278,-0.0241959123330881,0.0115093449118903,-0.0467542283603932,-0.00163759630578308,0.0355478434318917
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51562,-0.0446822278759466,0.0159045813165312,-0.0758552072563478,-0.0135092484955454,0.00496704632898629
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51562,-0.034209096773776,0.0102169852019918,-0.0542343877696799,-0.014183805777872,0.000814321167332789
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51562,-0.0682167375232485,0.0399090435772145,-0.146438462934589,0.0100049878880919,0.0874058668568552
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51562,-0.00898158074002674,0.010126494287127,-0.0288295095427957,0.0108663480627423,0.375119716073569
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51562,-0.0401927260270587,0.0120653060155165,-0.0638407258174711,-0.0165447262366463,0.000865678750788587
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51562,-0.0112152545299544,0.0136469402743687,-0.0379632574677169,0.0155327484078082,0.411189660057436
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51562,0.020455131838781,0.00482875409221519,0.0109907738180392,0.0299194898595227,2.28175820828496e-05
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28728,0.00304133775117431,0.0165597518601666,-0.0294157758947522,0.0354984513971008,0.854290141312984
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28728,0.0340346164674862,0.0218790839605195,-0.00884838809513206,0.0769176210301045,0.119882518116458
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28728,-0.0291952955469808,0.0145364294213178,-0.0576866972127637,-0.000703893881197893,0.0446611381368083
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28728,0.0332239860571798,0.0131348467942486,0.00747968634045247,0.0589682857739071,0.01145965659782
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51684,0.0117762952644917,0.00551527046706732,0.000966365149039784,0.0225862253799437,0.0327522453672313
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51684,-0.0074932280545377,0.0148754045078171,-0.0366490208898593,0.0216625647807839,0.614453283145722
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51684,0.0059565559932368,0.00537714555298367,-0.0045826492906112,0.0164957612770848,0.267977734828774
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51684,-0.00250870938090416,0.00536234864358522,-0.0130189127223312,0.00800149396052288,0.639904332166372
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51684,0.0301575116012799,0.00772629503549174,0.0150139733317161,0.0453010498708437,9.51456049815175e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51684,-0.0159567829841041,0.00685417935935049,-0.029390974528431,-0.00252259143977712,0.019917425695899
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51684,-0.00281214255570353,0.00575284708602166,-0.014087722844306,0.00846343773289893,0.624968662464259
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51684,0.0578022008217527,0.0156377015328273,0.0271523058174112,0.0884520958260943,0.000219162112851901
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43202,-0.0170468275112582,0.00574698541609473,-0.0283109189268039,-0.00578273609571253,0.00301864020462351
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43202,0.00597459130130144,0.0063688913114053,-0.00650843566905295,0.0184576182716558,0.34821040101451
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43202,0.0171574809767667,0.00639490021736037,0.00462347655074036,0.029691485402793,0.00730302304649613
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43202,-0.0150907951873769,0.00821581668193072,-0.0311937958839611,0.0010122055092073,0.0662555489338453
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43202,-0.00529386007782368,0.00579200086816457,-0.0166461817794262,0.00605846162377887,0.360731203661124
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51443,0.00217159727933095,0.00581701334733169,-0.00922974888143916,0.0135729434401011,0.70891452233439
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51443,-0.010967337122899,0.00468097508028894,-0.0201420482802653,-0.00179262596553265,0.019138658514931
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51443,0.00538402478423017,0.00512266450232003,-0.00465639764031708,0.0154244472087774,0.293258640175386
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51443,-0.0377404331027818,0.0112527077425999,-0.0597957402782777,-0.015685125927286,0.000797913676758933
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51455,-0.0195232466476456,0.00528695941588629,-0.0298856871027827,-0.00916080619250845,0.000222307584126627
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51455,-0.0460328473214763,0.00949500473620555,-0.0646430566044391,-0.0274226380385134,1.2533438313836e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51562,-0.0234602529343694,0.00504546214397925,-0.0333493587365687,-0.0135711471321701,3.33866351723796e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51562,-0.0310948988440961,0.00572906826483787,-0.0423238726431783,-0.0198659250450138,5.76171251216536e-08
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51562,-0.0130620015451678,0.00751086063002031,-0.0277832883800076,0.00165928528967198,0.082031714220535
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51562,-0.0302717327909989,0.0107898388517922,-0.0514198169405116,-0.00912364864148614,0.00502622256726102
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51562,-0.00190426494147551,0.0111522332953317,-0.0237626422003256,0.0199541123173746,0.86442013186847
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51562,-0.0460486518627415,0.0144053306733226,-0.0742830999824537,-0.0178142037430292,0.001391979242656
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39882,-0.00719306930922,0.0033219463073628,-0.0137040840716511,-0.00068205454678891,0.0303786337847478
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X864.Number of days or week walked 10+ minutes,51052,-0.0724499286583241,0.0296960863300194,-0.130654257865162,-0.0142455994514861,0.0147054210512589
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X874.Duration of walks,47058,-0.000726437571780522,0.00259406077348766,-0.00581079668781633,0.00435792154425528,0.779450327416506
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,49995,-0.0817832215443899,0.0288088240910675,-0.138248516762882,-0.0253179263258975,0.00453156558964538
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X894.Duration of moderate activity,43939,-0.051800183660334,0.0352878571880248,-0.120964383748863,0.0173640164281945,0.142138767087375
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30345,0.00129549474461611,0.00532088541861335,-0.00913344067586606,0.0117244301650983,0.807647064532776
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,49978,-0.161726474216834,0.029781236492337,-0.220097697741815,-0.103355250691854,5.67147802026068e-08
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X914.Duration of vigorous activity,37898,-0.00242595059973634,0.00348007098965371,-0.00924688973945761,0.00439498853998493,0.485753504535106
